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Abstract
The protein Memo (Mediator of ErbB2 driven cell motility) was identified
in a screen for ErbB2 receptor tyrosine kinase (RTK) interacting proteins
that have roles in cancer cell motility. A single Memo protein of 297 amino
acids is encoded in the human genome. Memo is evolutionarily conserved
and homologs are found in all branches of life. The human and the yeast
protein share an identity of more than 40% and a similarity of more than
50%. Memo is not homologous to any known signaling proteins and based
on its conservation we expect it to have functions in addition to promoting
motility in response to RTK activation. In the work described here, we
used the model organism S. cerevisiae to characterize Mho1 (Yjr008wp)
and to investigate its function in yeast. MHO1 expression is strongly in-
duced in conditions of stress. In stationary phase, one stress condition, a
high percentage of Memo is present in the nucleus. In mammalian cells,
Memo is also found throughout the cell. Memo has no obvious NLS (nu-
clear localization sequence), however, an NES (nuclear export sequence) is
present in all Memo homologs. In mammalian cells, blocking nuclear export
with Leptomycin B led to nuclear Memo accumulation, suggesting that it
is actively exported from the nucleus. Since invasive growth in S. cerevisiea
can be induced by stress, e.g., nitrogen deprivation, or alcohol induced, we
tested the role of Mho1 in this response. Deletion of MHO1 had no effect
on the formation of pseudohyphoa or invasion. Growth of mho1δ cells was
not affected by stress inducers including (HU, CoCl2, Heat-shock, Latrun-
culin, Nocodazol). Interestingly, however, overexpression of Mho1 blocked
the ability of the yeast cells to invade. In a synthetic lethal (SL) screen
we found MHO1 as a novel SL partner of PLC1. Plc1 is the only phos-
pholipase C in yeast and hydrolyzes phosphatidylinositol 4,5-biphosphate
(PIP2) to generate the signaling molecules inositol 1,4,5-triphosphate (IP3)
and 1,2-diacylglycerol (DAG). In the absence of MHO1 and PLC1, double
deleted spores still germinate but proliferation is impaired after 2 to 10
cell cycles by an unknown mechanism. Introduction of human MEMO into
the memo∆plc1∆ strain could rescue the SL phenotype showing that the
specific function of Mho1/Memo needed to overcome the synthetic lethal
phenotype is conserved.
”When Thomas Edison worked late into the night on the electric light, he
had to do it by gas lamp or candle. I’m sure it made the work seem that
much more urgent.”
George Carlin
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1.1 MEMO
1.1.1 The function of Memo in ErbB2 driven cell migration
The protein Memo (Mediator of ErbB2 driven cell motility) was identified in a screen
for ErbB2 receptor tyrosine kinase (RTK) interacting proteins that have roles in cancer
cell motility. A single Memo protein of 297 amino acids is encoded in the human
genome. Memo is evolutionarily conserved and homologs are found in all branches
of life. Downregulation of Memo in breast tumor cells resulted in a defect in cell
migration upon treatment with HRG, which has been shown to activate ErbB2-ErbB3
heterodimers and thereby stimulate migration. This indicates a critical role for Memo
in ErbB2 induced cell migration (67) (96).
Remodeling of the actin cytoskeleton, formation of lamellipodia and microtubule
outgrowth are critical steps during cell migration (61). Memo knockdown cells form
actin fibers and grow lamellipodia, but fail to extend microtubules towards the cell
cortex upon stimulation with HRG (67). In another study it was shown that the re-
duced microtubule network upon knockdown of Memo was caused by alterations in
the transition frequencies between microtubular growth and shortening phases. Addi-
tionally, Memo knockdown cells showed less small (short-lived) focal adhesions (FAs)
but more large FAs which are known to last longer (118). These results contribute to
the understanding of the motility defect in Memo knockdown cells as the short-lived
adhesion sites are known to be involved in membrane protrusion whereas large FAs are
required for the anchoring of a cell (52).
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To investigate how Memo influences the organization of the lamellipodial actin net-
work, studies with mDia1, which is known to control actin polymerization, and the
RhoA guanosine triphosphatase were performed. Memo was found to be required for
the localization of the active GTP-bound RhoA and its effector mDia1 to the plasma
membrane. It was shown that Memo-RhoA-mDia1 coordinates the formation of fo-
cal adhesions, microtubular outgrowth and the organization of the lamellipodial actin
network (118).
Memo and PLCγ interact with specific ErbB2 phosphorylation sites (Figure 1.1),
and both were shown to be essential for HRG induced chemotaxis. Upon Memo or
PLCγ knockdown, cells can still migrate, although to a lesser extent, but lose the
ability for directional cell migration. A reduced HRG-induced phosphorylation level of
PLCγ was observed in Memo knockdown cells suggesting that Memo regulates PLCγ
activation by a still unknown mechanism. In a screen for interaction partners of Memo,
cofilin, a member of the actin depolymerizing factor (ADF)/cofilin family was identified
(70). Proteins of these family control actin-filament assembly and disassembly, which is
required for cell migration (26). It was shown in an invitro assay that Memo enhances
cofilin depolymerizing activity, which suggests a role of Memo in the control of actin
dynamics (70). Together these results strongly support an important role of Memo in
ErbB2 induced cell migration. Memo is likely to be involved in several important steps
in cellular migration, as its involvement in the organization of the actin network, in the
formation of focal adhesions and microtubular outgrowth has been demonstrated.
1.1.2 Memo protein structure is homologous to nonheme iron dioxy-
genases
The crystal structure of the full-length human Memo protein was determined by Qui et
al. using a single wavelength anomalous diffraction (89). The resulting atomic model
was then refined to a 2.1 A˚ resolution. Only the last 5 N-terminal amino acids could
not be modeled. The modeled Memo structure adopts a single domain structure with
a mixed seven-strand β-sheet surrounded by nine α-helices (Figure 1.2). The β-strands
and the α-helices have been designated with numbers, letters respectively, according
to their appearance in the primary sequence (Figure 1.2). With the program DALI a
search for structural Memo homologs revealed that Memo is homologous to LigB, the
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Figure 1.1: ErbB2/ErbB3 heterodimer and autophosphorylation - ErbB2 and
ErbB3 form a heterodimer upon HRG (heregulin) binding to the extracellular domain
of ErbB3. The heterodimerization leads to the autophosphorylation of the intracellular
phospho-Tyrosine sites of ErbB2, PTyr-1023, PTyr-1139, PTyr- 1196, PTyr-1222, and
PTyr-1248. The phospho-Tyrosine sites of ErbB2 are shown as orange ovals and the sites
are named YA - YE (22). The YC (81, 83), YD (67),and YE sites (46) are known to have
a role in cellular migration. Memo was found to bind the P-YD peptide site (67) directly,
in cells it is likely to be via Shc (Src homology 2 domain containing).
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catalytic β-subunit of the protocatechuate 4,5-dioxygenase LigAB from Sphingomonas
paucimobilis (47)(102).
LigAB is a class III nonheme iron(II)-dependent extradiol-type catechol dioxyge-
nase that catalyzes oxidative cleavage of substituted catechols in bacterial aromatic
degradation pathway (76). The primary protein sequence homology between Memo
and class III nonheme iron(II) dependent dioxygenases is low, the identity is less than
15%. The catalytic activity of LigB is mediated by an iron ion, which is coordinated
by the amino acids His-12, His-61, Glu-242, and a water molecule (102) (Figure 1.2).
A third histidine, His-195, is believed to function as a general base during catalysis.
All three histidine are conserved in Memo and have the number His-49, His-81, and
His-192, respectively. But the Glu-242 of the LigB is missing in Memo and was replaced
by a cysteine (Cys-244) (Figure 1.2). This substitution does not necessary exclude the
possibility of a metal binding. The cysteine side chain is capable of coordinating many
metal ions including iron. Memo has also an aspartic acid at position 189 (Asp-189)
the side chain of which could coordinate a metal ion bound at this site and balance the
positive charge. As all known LigB non heme dioxygenases members in bacteria have a
glutamate in the active site it is unlikely that Memo has the same function. However,
the possibility that Memo has an enzymatic function has not been excluded.
Recently a 2.3 A˚ crystal structure of the uncharacterized E. coli protein ygiD
(JW3007) has been released. This E. coli protein has been shown to be an other
structural homolog of Memo. ygiD shares only 11% protein sequence homology to
Memo, but clearly shares the same structural topology with Memo (Figure 1.2). The
yigD protein coordinates three zinc ions, one of which is positioned in a site homologous
to the putative metal-binding site in Memo. This zinc ion is ligated by a water molecule
and three histidine (His-22, His-57,and His-234). These 3 histidine correspond to the
residues His-49, His-81, and Cys-244 in Memo.
1.2 Why study MEMO in Saccharomyces cerevisiae?
Saccharomyces cerevisiae is maybe the most useful yeast species. It has been used
since ancient times for baking and brewing, most of the time even without people
knowing and realizing it. S. cerevisiae, it is believed, was originally isolated from the
skin of grapes (yeast is one component of the thin white film one can see on the skin
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Figure 1.2: Memo and the structural homology to a Nonheme Iron Dioxyge-
nases - 1) ribbon diagram of Memo in stereo. Side chains of His-49, His-81, and Cys-244
are shown as green sticks. 2) ribbon diagram of LigB (Protein Data Bank code 1BOU).
The iron ion is indicated by a red sphere, and the residues coordinating the iron, His-12,
His-61, and Glu-242, are shown in green. 3) ribbon diagram of ygiD (Protein Data Bank
code 2pw6). The zinc ion is indicated by a magenta sphere, and the residues coordinating
the zinc, His-22, His-57, and His-234 are shown in green (Figure adapted from (89)).
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of dark colored fruits like plums or grapes). S. cerevisiae is not only indispensable in
the kitchen, but also in research it has become a model organism in cell biology. It is
one of the most studied eukaryotic cells and has a status comparable to Escherichia
coli as the model bacterium. S. cerevisiae cells are 5 - 10 micrometers in diameter and
often ovoid shaped. The single celled yeasts reproduce by budding of a daughter cell
from the mother cell. During ”normal” proliferation the mother cells grow a bud which
then develops to their daughter cells. Most types of fermentation are driven by the
microorganism S. cerevisiae.
Below some aspects are listed guessing why S. cerevisiae has developed as a model
organism:
• As a single celled organism S. cerevisiae is small with a short generation time
(doubling time 90 minutes at 30◦C (103)) and can be easily cultured. The pro-
duction and maintenance of multiple specimen lines can be kept at low cost.
• S. cerevisiae can efficiently be transformed through homologous recombination
allowing for either the addition of new genes or deletion of genes. Furthermore,
the ability of growing S. cerevisiae as haploid cells simplifies the production of
gene knockouts strains or whole gene deletion collections.
• As a eukaryote, S. cerevisiae shares most of the major cell structure complexes
with other eukaryotic cells like plants and animals. However, S. cerevisiae does
not have the high percentage of non-coding DNA found in most ”higher” eukary-
otes.
• Many important and conserved proteins were first discovered and studied in yeast
before the mammalian homolog was found and studied. Some of these proteins
include cell cycle proteins, signaling proteins, and protein-processing enzymes.
Also in terms of tools, large-scale screens, genetics, and many more reasons S.
cerevisiae has developed as a major model organism::
• Genome sequencing
The first eukaryotic genome that was completely sequenced was the one from
S. cerevisiae (39). On April 24, 1996, the genome sequence was made public
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and since then regularly updated at the Saccharomyces Genome Database (SGD
(28)). The SGD is highly annotated and cross-referenced and one of the tools
frequently used by yeast scientists. The S. cerevisiae genome is composed of
about 12’000 kilo base pairs (kbp) and approx. 6’300 genes, compactly organized
on 16 chromosomes. Only about 5,800 of these are believed to be true functional
genes. About 23% of the yeast genes (approx. 1’500 genes) do have a human
homologous gene with an percent identity ≥ 30% (13).
• Other tools in yeast research
One of the main features in S. cerevisiae research is the availability of the en-
tire genome sequence and different sets of commercially available deletion strains
(invitrogen). But also the development of protein interaction screens made S.
cerevisiae a powerful model in many branches of science.
• Yeast cell-based assays for receptor tyrosine kinases (RTKs)
The major working model for Receptor Tyrosine Kinases (RTKs) is the homo- or
hetero-dimerization after ligand binding. This dimerization leads to the activation
resulting in phosphorylation at specific Tyrosine residues. RTKs are regulator of
various intracellular signaling-transduction pathways and enhanced RTK activ-
ity, due to mutations, overexpression or other, is associated with various human
diseases.
The advantage of studying RTKs in yeast is the fact that yeast cells do not have
endogenous RTKs. This means there is no interference from redundant processes
like other RTKs activating downstream signaling. The assay is specific and clean.
By doing experiments in yeast the RTKs are still in an eukaryotic environment.
This is advantageous as this addresses cell-compatibility and membrane perme-
ation. In screens for small chemical inhibitors the eukaryotic environment facili-
tates the elimination of metabolic unstable and toxic components.
In S.cerevisiae it is possible to do reliable HTS (High-throughput) assays which
are relatively rapidly established and are very cost-effective.
In yeast the specific control is already built-in due to the absence of endogenous
Tyrosine-kinases.
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• Bar-coded yeast are discussed in more detail in the section 1.2.4 Bar-coded yeast
and the Saccharomyces genome-deletion project.
• Astrobiology
A sample of S. cerevisiae will be included in the Living Interplanetary Flight
Experiment. The plan is to send a small sample on a three-year interplanetary
journey in the Russian Fobos-Grunt spacecraft (19). Main objective of the mission
is to test if the selected organism can survive some years in deep space. The
researches want to test the hypothesis if life can survive space travel, if for example
protected inside a rock and so bring live to other planets.
• Brewing
Beer-Brewers classify Saccharomyces cerevisiae ”top cropping” (or ”top-fermenting”)
and ”bottom-cropping” (or ”bottom-fermenting”) (? ). Top cropping (or ”top-
fermenting”) yeast, as its name says, are found in the foam arising during the
fermentation process. The hydrophobic surface of the yeast clumps, so called
flocs (flocculated yeast: cells tend to stick together once all sugar has been fer-
mented into etanol) adhere to produced CO2 and due to this effect are found
on ”top”. ”Bottom-cropping” (or ”bottom-fermenting”) yeasts are used to brew
lager or ale beer. In contrast to top cropping yeasts Bottom-cropping yeasts need
lower temperatures for fermentation. A bottom-cropping yeast is Saccharomyces
pastorianus which was also known as S. carlsbergensis.
The different yeast strains used for beer brewing are chosen accordingly to the
kind of beer one wants to get. As a yeast population in not genetically identical,
but shows random variation, the nowadays typically, and unique for each beer,
yeast strains could be ”selected” and grown. For example cells that stay in
suspension and flocculate later tend to end up at the top of the yeast bed and
can easily be collected and be reused for the next brewing. Repetition of the
selection for a specific cretiria will change the profile of the culture and alter
fermentation characteristics.
Nutritional requirements for growth of S. cerevisiae:
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For aerobic growth all S. cerevisiae strains need the sugars glucose, maltose, and
mycose, but can not use lactose and cellobiose. Depending on the genetic background
an on whether the yeast grow aerobically or anaerobically they use different sugars. For
example the best fermenting sugars are galactose or fructose. Common for all strains
is that they can use ammonia and urea as the unique nitrogen source. As yeast can
not reduce nitrate to ammonium ions this nitrogen source is not usable for yeast. On
the other hans they can use most nitrogen bases, amino acids, and small peptides, as a
nitrogen source. As textitS. cerevisiae does not excrete proteases extracellular protein
cannot be used as a source for their metabolism.
1.2.1 Mating type and the life cycle of Saccharomyces cerevisiae
Saccharomyces cerevisiae is a single celled eukaryote with two variants of existence, as
diploid and haploid cells. Only haploid yeast cells can mate. The cells can be either a or
α (alpha) mating type and thus display simple sexual differentiation. The mating type
of the cells is determined by a single locus, MAT, which controls the sexual behavior
of both haploid and diploid cells. Haploid yeast can switch the mating type as often as
every cell cycle through a form of genetic recombination. S. cerevisiae can stably exist
as either a diploid or haploid. Haploid and diploid yeast cells reproduce by mitosis,
with daughter cells budding off from mother cells. Haploid cells are capable of mating
with other haploid cells of the opposite mating type (an a cell can only mate with an α
cell, and vice versa) to produce a stable diploid cell. If diploid cells are facing stressful
conditions such as nutrient depletion, they can stop proliferating and instead undergo
meiosis to produce four haploid spores: two a spores and two α spores.
1.2.1.1 What are the Differences between a and α cells?
The two opposite mating type cells produce two distinct mating type pheromones to
signal their presence and attract cells from the opposite mating type. This means that
a cells produce a-factor, to signal their presence to an α cell. On the other hand a cells
respond to the mating pheromone of an α cell, called α-factor, by growing a projection
(known as a shmoo, due to its appearance resembling the famous cartoon characters
(see Figure 1.3) towards the source of α-factor).
In an analogous manner, α cells respond to a-factor by outgrowing a shmoo toward
the source and producing the α-factor. The mating response is only induced if a haploid
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Figure 1.3: SHMOO - A SHMOO as it first appeared in ”Li’l Abner” in August 1948,
by Al Capp.
cell senses the mating pheromone of the opposite mating type, but not by the same
mating type. The accurate regulation of mating type specific genes in the cells of the
two mating types leads to the phenotypic differences. An a cell activates genes which
produce a-factor and the a cell specific cell surface receptor (Ste2). Ste2, also called
α-factor receptor, binds to α factor which then triggers signaling within the cell. Genes
associated with being an α cell are repressed in a cells. Similarly, α cells activate
specific genes to produce α-factor and Ste3 (a cell surface receptor) which binds and
responds to a-factor. On topα cells repress gene transcription of genes associated with
being an a cell. The presence of one of the two alleles of the locus called MAT : MATa
or Matα causes the different sets of transcriptional repression and activation which
characterize a and α cells. The MATa allele of MAT encodes a gene called a1, which
then regulates the a-specific gene transcription (e.g. expressing STE2 and regressing
STE3 ).The MATα allele of MAT locus encodes the α1 and α2 genes, which regulate
the transcription of the α-specific transcriptional program (e.g. expressing STE3 and
repressing STE2 ).
1.2.1.2 What are the differences between haploid and diploid cells?
Haploid yeast cells can can have one of the above mentioned mating type, either a or
α. If two cells of opposite mating type sense each other by recognizing the pheromones
they can extend a shmoo and fuse their cell wall, cytoplasm, and nuclei and by this
becoming a diploid cell (Figure 1.4).
The haploid yeast cells proliferate by undergoing mitotic cell divisions but cannot
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Figure 1.4: Mating of yeast cells - 1. A red MATa cell secretes the a mating pheromone
and expresses the α-factor receptor on its surface, whereas a blue MATα cells secretes the
α-factor pheromone and expresses the a-factor receptor 2. Upon recognition of the opposite
mating pheromone the cells stop in cell cycle in G1 and extend a shmoo toward the source
of the mating factor 3. When the two opposite mating type cells meet they first fuse their
cell wall and membrane and mix their cytoplasm followed by fusion of the two nuclei to
become a diploid cell.
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undergo meiosis. In contrast in diploid cells the production or response to either mating
pheromone is repressed and due to this they can not mate. However, under specific
environmental growth conditions diploid yeast cells can undergo meiosis to produce four
haploid cells (spores). As described for the difference between the two mating types, the
phenotypic differences between haploid and diploid yeast cells is regulated at the level
of gene transcription. Haploid cell not only have a specific transcriptional pattern for a
and α mating type, they both share a specific haploid transcriptional pattern. Haploid
yeast cells transcribe haploid-specific genes like HO, but actively repress diploid-specific
genes like IME1. On the other hand, diploid cells enforce transcription of diploid-
specific genes and repress the transcription of diploid-specific genes. This described
difference in expression patterns between haploid and diploid cells is due to the MAT
locus. Haploid cells only have one copy of each of the 16 chromosomes in S. cerevisiae
and so by definition can only have one allele of MAT (either MATa or MATα). The
one MAT locus they posses determines their mating type. Two haploid yeast cells of
opposite mating type become one diploid yeast cell after mating. The mating results
in a cell having 32 chromosomes (in 16 pairs), one chromosome encoding the MATa
allele and another chromosome encoding the MATα allele. The combination of the
two opposing MAT alleles triggers a diploid-specific gene transcription program. In
haploid cells only one MAT allele can be present. The of genetic information of only
one MAT allele starts the haploid-specific gene transcription program. The fact that
the information encoded by the MAT locus is enough the explain the mating-type
behavior can be showed nicely by some genetic manipulations of haploid and diploid
cells. For example if a haploid cells gets an extra-copy of the opposing MAT locus it
starts to behave like a diploid cell. In contrast by deleting a MAT allele in a diploid
cell will force the cell to behave like a haploid cell
1.2.1.3 Isotropic vs. polarized growth
In all kingdoms of life there are cells that can polarize in response to external (e.g.
chemical gradients, cell-cell contacts, or environment) and/or internal stimuli. In gen-
eral eukaryotic cells react to these stimuli by assembling a polarized actin cytoskeleton
at the cellular cortex. Together with microtubules it coordinates the guidance of mem-
branes. Recruitment and rearrangement of actin and mirotubules finally leads to polar-
ized events internally and at the cell surface (27). S. cerevisiae uses polarized growth
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to direct the budding of the daughter cell from the mother during cell replication and
shmoo formation as a response to mating pheromones. the following steps are essential
to guarantee cell growth in S. cerevisiae:
1. Weakening of the cell wall by digestive enzymes to allow cell expansion
2. Insertion of new plasma membrane at the cell surface
3. Synthesis of a new cell wall by biosynthetic enzymes
For polarized growth the secretory pathway has to deliver the needed enzymes
and membranes to discrete growth sites at the cellular surface. Adams and Pringle,
1984 (2) showed that actin localizes to sites of cell expansion during the cell cycle.
Work following this break through showed that secretory vesicles are transported only
along actin cables to support growth, instead of actin cables and microtubules like
most ”higher” cells (for review, see (15)(30)). Actin also orients the mitotic spindle at
early stages of cell division by microtubule-actin interactions (104). The inheritance of
mitochondria, peroxysomes, and the vacuole into the bud depends on the polarization
of the actin cytoskeleton. Almost all aspects of polarized growth in yeast start from the
polarity of the actin cytoskeleton. Thus, it is important that elaborate controls carefully
monitor and regulate cytoskeletal structure during all steps of the yeast cell cycle. In
yeast, F-actin is manly organized into cortical actin patches and actin cables. Cortical
patches are discrete F-actin rich bodies, whereas actin cables are long F-actin bundles
(2)(4). Cables and patches are polarized in a cell-cycle-dependent manner and are
located at the cell cortex. If the cell enters a new round of cell cycle in G1 (Start), the
first step is to select the site of budding (Figure 1.5) (87). Actin patches, which bundle
the actin cables for membrane and enzyme transport, form an actin ring. As soon as a
bud emerges, cortical actin patches cluster at its tip thereby extending actin cables from
the mother cell into the bud and the bud grows apically (from the tip). While the bud
is still growing, patches and cables within the bud redistribute randomly while the actin
cables in the mother cell still extend to the bud neck thus providing the daughter cell
with the needed organelles, membranes and proteins. The bud expands isotropically
into an ellipsoid shape. An alternative filamentous morphology that is induced in
some S. cerevisiae strains by a variety of environmental growth conditions leads to the
prolongation of apical growth to generate highly elongated cells, called pseudohyphal
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or filamentous growth ((Figure 1.5); (56)(63)(66). At the end of vegetative bud growth,
a cytokinetic F-actin ring assembles at the bud neck, contracts and disassembles the
daughter from the mother cell (29). After cytokinesis, patches and cables in the mother
and daughter repolarize to the site of cell scission to direct synthesis of cell walls between
the two new cells.
During the mating response and the following schmoo formation actin also has to
polarize (Figure 1.5). Pheromone stimulated cells become arrested in G1 and start to
express the needed proteins for polarized growth and orient growth toward the source
of the mating pheromone. The yeast cells polarize their actin cytoskeleton by sensing
the pheromone concentration gradient (56). During bud formation, almost all growth is
directed into the bud. In a proliferating population uniformly sized mother cells having
variously sized buds can be found. If the polarized growth is defective the cells have
either elongated buds as a consequence of excessive apical growth, or have spherical
buds as a consequence of excessive isotropic growth. When growth is only isotropic,
this means completely undirected, bud formation is completely abolished and mother
cells grow into huge, round, and unbudded cells.
The key player that regulates actin polarization is the essential Rho GTPase Cdc42.
Cdc42 controls the polarization of the actin cytoskeleton during the different phases of
cell cycle. Essential for this regulatory function is the recruitment of Cdc42p to growth
sites on the plasma membrane, where the GTPase activates effectors that signal to the
actin cytoskeleton (119). The loss of Cdc42 leads to large, round, unbudded cells due
to the disorganization of the actin patches and cables (Adams et al., 1990). In mutants
in which Cdc43vlose this ability to localize to the plasma membrane polarization is also
lost (1). Like other Rho GTPases, Cdc42p signals to effectors only in an active GTP-
bound state. GTP binding requires the guanine-nucleotide-exchange factor (GEF)
Cdc24 (44). Normal Cdc42p function also requires inactivation by GTP hydrolysis
(Figure 1.6 b)).
1.2.1.4 Filamentous growth of Saccharomyces cerevisiae
Fungal dimorphism is a complex phenomenon induced by a large variety of environ-
mental factors. Cells switch from ”normal cell division cycle” to a reversible alternating
pattern of growth between elliptical and filamentous forms of cells. When diploid S.
cerevisiae sense a lack of nitrogen in their environment cells stop budding and form
1.2. WHY STUDY MEMO IN SACCHAROMYCES CEREVISIAE? 15
G
1
G
2
M
S
a
b
c
d
e
f
g
Figure 1.5: Cell polarity in budding yeast - Polarized growth sites (red), where the
Rho GTPase Cdc42 is active, change during the cell cycle and so also reorienting the actin
cytoskeleton via Cdc42 related proteins. In turn, the actin cytoskeleton guides secretory
vesicles to the cell surface, where they accumulate (red) and fuse. (a) The cell cycle begins
in G1 with establishment of a nascent bud site. (b) Clustering of Cdc42p directs early bud
growth toward the tip. (c) Redistribution of Cdc42p over the bud surface during G2-M
redirects bud growth isotropically, and results in an ellipsoidal shaped bud. (d) With the
completion of bud growth, cables and patches disorganize, and a cytokinetic ring forms,
then contracts and disassembles after mitosis. Cdc42p reorients actin and growth between
the two new cells to generate new cell walls. The mother cell resumes budding immediately.
(e) The new daughter undergoes a period of undirected growth. (f) Mating pheromones
arrest haploid yeast in G1 and polarize Cdc42p toward potential mating partners to gen-
erate a mating projection (shmoo) (g) Under certain growth conditions, some strains of S.
cerevisiae differentiate into a filamentous state that leave out the transition in G2-M from
tip-directed to isotropic growth. The resulting cells are highly elongated.
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pseudohyphae . By switching from budding to filamentous growth the cells get an ad-
vantage in nutrient retrieval. This nitrogen sensing process is at least controlled by at
least two signaling transduction pathways:
1. The MAP kinase (MAPK) pathway (Figure1.6)
2. The PKA (cAMP-dependent protein kinase A) pathway (Figure 1.6)
Both pathways activate the expression of pseudohypha-specific genes and lead to a
G2 delay in the cell cycle for a prolonged period of polarized growth.
Haploid yeast cells show a similar pseudohyphal growth phenotype after running
short of nutrients. This happens if yeast cells were grown for several days on rich
medium plates. In contrast to the diploid cells, haploid cells do not elongate in shape
but they form chains and invade into the agar on the edge of the colony. This growth
form is referred as haploid invasive growth. Another stimulus which can induce fila-
mentous growth in haploid and diploid cells is alcohol (64). The yeast cells become
aberrant and elongated in shape.
1.2.2 The filamentous fungus Ashbya gossypii (from the master the-
sis ”Function of the four homologs of yeast Dynamins in the
filamentous Ascomycete Ashby gossypii”, I. Schlatter, 2005)
The filamentous fungus Ashbya gossypii, an Ascomycete, belongs to the order of En-
domycetales in the family of Saccharomycetaceae (86). Ashby and Nowell first described
this fungus in 1926 as a cotton pathogen that can also infect citrus fruits and toma-
toes (6). Stigmatomycosis, the disease caused by Ashbya, affects the development of
hair cells in cotton bolls and leads to dehydration and collapse of infected citrus fruits
(6)(98). Insects such as Antestia and Dysdercus spread the disease from plant to plant.
The needle-shaped spores of A. gossypii stick to the body of insects while they are visit-
ing Ashbyas host plants [4]. On a medium, favorable for germination, the development
of A. gossypii starts with a phase of isotropic growth (Figure 1.7).
The middle part of needle-shaped spores forms a germ bubble, in which actin patches
localize randomly at the cortex. Afterwards, actin patches start to concentrate at one
region at the cortex perpendicular to the axis of the needle, thus marking the site of
germ tube emergence. This polarized actin cytoskeleton directs growth from this region
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Figure 1.6: cAMP-PKA pathway and MAPK pathway - a) cAMP-PKA pathway
regulates filamentous growth in S. cerevisiea. Activation of Ras2 stimulates the adenylate
cyclase, Cyr1, and the resulting increase in cAMP level causes an activation of the Tpks
(Tpk1,2,3 are the 3 catalytic subunits of the yeast PKA homolog (highlighted in blue),
whereas Bcy1 is the regulatory subunit). These specifically activate or inhibit a number
of proteins which act on different target genes. b) In S. cerevisiae filamentous growth is
regulated by the MAPK pathway. Ras2 gets activated by external signals which, in turn,
causes the phosphorylation of the MAPKKK Ste11, The MAPKK Ste7, and the MAPK
Kss1. The genes which are targeted by this signal cascade have a FRE element in their
promoter.
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Figure 1.7: Development of A. gossypii. - The pictures represent cross section
through A. gossypii at different developmental stages. The red dots represent actin patches,
the red lines actin cables and the red ellipses actin rings. (a) Ungerminated spore. (b), (c)
Formation of a germ bubble by isotropic growth. The actin patches are distributed evenly
among cell cortex. (d) Concentration of actin patches to the site of branch emergence. (e)
Unipolar germling actin patches are concentrated at the site of growth, and actin cables
are reaching from the tip into the germ bubble. (f) Continued apical growth phase in
the unipolar germling. Actin patches are concentrated at the tip. The very apical part
is free of actin patches. Actin cables run along the hyphal cortex. (g) Emergence of a
second germ tube. An actin ring localizes to the neck between the first germ tube and
the germ bubble as a precursor for septation. (h) Emergence of the first lateral branch,
and induction of a septum at the neck where the actin ring was localized. Actin patches
localize transiently at the site of septum formation. (i) Continued apical growth at all tips.
The generated septum is now free of actin. (j) Apical branching in mature hyphae. (k)
Sporangia containing spores.
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causing the first germ tube to extend and form a unipolar germling. Actin localizes as
cortical patches to the tip of the germ tube and less frequently to the hyphal cortex.
Actin cables run from the tip into the hypha. The germ tube maintains polarization
and extends consistently in one direction. On the opposite side of the germ bubble,
a second germ tube is formed to give rise to a bipolar germling. Additional sites of
polarity are established at the hyphal cortex and initiate lateral branches. Actin rings
are formed at sites that will later form septa, a chitin-rich ring-like structure. The
first septum is preferably formed at the neck between the germ bubble and the first
germ tube. The speed of hyphal tip growth increases during maturation and apical
tip branching occurs in mature mycelium(7)(109)(110). As no cytokinesis occurs in A.
gossypii, hyphae consist of multi-nucleated compartments that are only intersected by
septa. After 5 - 8 days, depending on environmental conditions, the mycelium forms
vegetative spores. These spores attach to each other through a filament (Figure 1.8).
Figure 1.8: Sporangium with spores attached to each other. - As A. gossypii does
not undergo cytokinesis this fungus has a multinucleate cytoplasm. Segments of hyphae
containing 8 nuclei are enclosed by single actin rings which then duplicate and contract.
The formed septum then separates 8 nuclei compartments from each other in the older
parts of the filament. If the fungus grows for several days on the same plate nutrients gets
limited and A. gossypii can form spores. A septum containing the 8 nuclei can produce a
Sporangium with 8 spores. As A. gossypii is always haploid it does not need to undergo
Mitosis during sporulation, like the diploid S. cerevisiae cells, but can directly produce a
sporangium with spores. The spores are needle shaped and can stick to the body of insects
while they are visiting A. gossypii host plants. In the figure the sporangium has lost two
cells, so only six spores are visible.
For the haploid A. gossypii no sexual cycle is known. The genome of Ashbya
gossypii contains most homologs of the genes that are part of the Saccharomyces cere-
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visiae pheromone-signal transduction cascade. However, the sequenced strain bears
three identical copies encoding MATa. Some finding now showed, that there could
be a sexual cycle even in A. gossypii in nature (111). Ashbya gossypii naturally pro-
duces and excretes riboflavin, vitamin B2, in large quantities (113), which makes it
interesting for biotechnological purposes. Like two other overproducers of this vitamin,
Candida famata and Bacillus subtilis, Ashbya is currently used in industrial riboflavin
production. Thus, chemical production of this vitamin is now replaced by microbial
processes, which reduce costs as well as waste and energy consumption while using re-
newable resources (97). In order to optimize biosynthetic processes, molecular tools in
respective organisms have to be developed. A. gossypii does integrative recombination
exclusively via homologous recombination (99). This allows PCR-based one-step gene-
targeting (106). A PCR generated knockout cassette consists of a dominant selectable
marker, which is flanked by short guide sequences with 40 – 46 bp of homology to two
sequences of the targeted gene (109). In this study, we used sequences with 50 – 60
bp homology to reduce the number of false positives and to increase efficiency. GEN3
is a nonhomologous selection marker, constructed for the use in A. gossypii. It con-
sists of the E. coli kanR gene under the control of promoter and terminator sequences
of the highly expressed S. cerevisiae TEF2 ORF, thus preventing recombination with
A. gossypii promoter and terminator sequences. GEN3 mediates resistance against
G418/geneticin (109). The advantage of this fast growing fungus compared to S. cere-
visiae is, that it needs sustained polarization at the growing hyphal tip. For this the
interplay between the cytoskeletal structures like actin and micro tubules but also the
correct localization of polarization determining protein is essential (54).
1.2.3 Synthetic lethality in Saccharomyces cerevisiae
Synthetic lethality is commonly known as the genetic interaction of two by its own
not lethal mutations but when combined in one cell are lethal (25). SL has been one
of the most powerful tools to elucidate the functions of many yeast genes (10). By
doing global synthetic lethality analysis yeast scientists hope to identify the cellular
pathways that can compensate for each other biologically (43). Of the approximately
6000 yeast genes 4800 single deletions strains are viable when plated on full medium
plates at standard conditions. This means the proteins encoded by one of this 4800
genes is not needed under this condition. Also possible is that the protein function of
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the deleted gene or the pathway in which it signals can be complemented by another
protein/pathway bypassing the lack of one protein. Only if both genes are deleted,
which means both pathways are interrupted, the double deleted cells die (Figure 1.9).
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Figure 1.9: Synthetic lethality - Approximately 4800 yeast genes are not essential
because other gene products / pathways buffer against their loss. But if two single deletions,
which alone are viable, are combined and the yeast do not grow it is called synthetic
lethality.
Most signaling pathways are not completely separate from each other, but are in-
terconnected at many steps and can signal or inhibit to each other. It is not enough to
interrupt two pathways by deleting two random genes of the parallel pathways, but it
is necessary to hit two proteins needed in pathway steps were there is no compensation
by the other. To fully understand two pathways and identify all the inter-pathway
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cross-talk it is necessary to make all the possible double deletions with all the genes
involved. After analysis of the viable, slower growing and dead double deletions it could
be possible to understand how the two ”separate” pathways are regulated by each other
((Figure 1.10)).
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Figure 1.10: Genetic interaction Profile - In theory one could use the idea of synthetic
lethality to build up networks of pathways based purely upon genetic analysis.
If the concept of synthetic lethality is thought further the logical consequence would
be to find all the synthetic lethal partner of one gene of interest, the ”query strain”.
As query strain a haploid strain with the deletion of ”your favorite gene” (YFG) is
used. The yfg∆ strain is then consequently mated to a collection of the 4800 viable
haploid single deletion strains of the opposite mating type which are pinned on agar
plates. Each of the 4800 single deletion strain has it defined spot on the agar plates.
The resulting diploid strains are heterozygous for YFG and one of the non essential
genes. The newly created diploid strains are then sporulated and the now haploid yeast
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cells are selected for the double deletion. No one can look for spots on the agar plates
were slow growing ore non growing colonies can be detected which indicates a ”negative
genetic interaction” (Figure 1.11).
This method is robust but a lot of special plates for the pinning robot devise are
needed with different selection and sporulation media. The analysis can be done by
eye or colony-size can be detected by camera and analyzed by a software (21). The
ultimate goal would be to get a data grid with the crossing of all 4800 haploid single
deletion strains against each other.
1.2.4 Bar-coded yeast and the Saccharomyces genome-deletion project
The Saccharomyces genome-deletion project is a worldwide collaborative effort to cre-
ate a systematic deletion collection for almost all annotated yeast ORFs. The single
gene deletions were made by replacement with the kanMX4 cassette that confers re-
sistance to the drug G418 (114). These ’yeast knockout’ (YKO) mutants were created
by chromosomal integration of PCR-generated disruption cassettes via homologous re-
combination (Figure 1.12). The YKOs exist in four formats (114):
1. MATa haploid
2. MATα haploid
3. MATa and MATα homozygous diploid (used for HOP - Homozygous deletion
Profiling)
4. MATa and MATα heterozygous diploid (used for HIP - HaploInsufficiency Pro-
filing)
The first three sets (MATa haploid, MATα haploid, MATa and MATα homozygous
diploid) contain only nonessential gene YKOs whereas the heterozygous diploid deletion
collection contains approximately 96% of the yeast genome which is over 6000 individual
yeast strains. These YKO mutant collections perfect for large-scale screens to analyze
genome functionality. They have been used to study gene-function in a variety of bi-
ological processes, cellular response to various stresses and drugs resistance. In Ron
Davis’ laboratory these deletion collections were developed further by the systematic
incorporation of unambiguous DNA sequence identifiers called ”TAGs” in each mutant
24 1. INTRODUCTION
x
querry
yfk::natMX
4800 non essen-
tial single gene 
deletion strains
xxx::kanMX
MATa MATα
yfk::natMX xxx::kanMX
Mating
yfk::natMX
xxx::kanMX
YFG
XXX
MATa
MATα
Sporulation
α
α
a
a
yfkΔ
yfkΔ
YFG
YFG
XXX
XXXxxxΔ
xxxΔ
α
a
a
yfkΔ
yfkΔ
YFG
YFG
XXX
XXXxxxΔ
xxxΔ
α
Selection for haploid MATa cells
 can1::MFA1pr-HIS3
MATα
xxx::kanMX
MATα MATαMATα
xxx::kanMX
yfg::natMX YFG
yfg::natMX
XXX XXX
YFG
Double mutant selection
Medium with G418 & ClonNat
MATα
xxx::kanMX
yfg::natMX
4800 double-deleted strains. If YFG is SL with 
some other genes, those strains are not grow-
ing on the plate with the final selection.
Figure 1.11: Synthetic genetic array (SGA) - A MATα strain (red) carrying a
query mutation (yfg∆) linked to a dominant selectable marker, such as the nourseothricin-
resistance marker natMX that confers resistance to the antibiotic nourseothricin (clon-
NAT), and the MFA1pr-HIS3, is mated to a collection of MATa (blue) viable yeast deletion
mutants, each carrying a gene deletion mutation (xxx∆) linked to a kanamycin-resistance
marker kanMX that confers resistance to the antibiotic geneticin (G418). Growth of re-
sultant diploid zygotes is selected for on medium containing nourseothricin and geneticin.
The heterozygous diploids are transferred to medium with reduced levels of carbon and ni-
trogen to induce sporulation and the formation of haploid meiotic spores. These spores are
transferred to synthetic medium lacking histidine, which allows for selective germination
of MATa spores because only these cells express the MFA1pr-HIS3 reporter. The MATa
cells are then transferred to medium that contains G418 and clonNAT, which then selects
for growth of double mutant (yfg::natMX xxx::kanMX ).
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Figure 1.12: Genotype of a barcoded heterozygous deletion strain - A diagram
for the yeast knockout construct. Each YKO consists of a kanMX module that confers
resistance to the antibiotic G418 flanked by unique 20-mer molecular barcodes or Tags
called the Uptag and Downtag. All Uptags and all Downtags are themselves flanked by
two common set of priming sites (U1 and U2 for the ”Uptags” within the orange circles)
and (D1 and D2 for ”Downtags” within the cyan circles). By using these common priming
sites all Uptags or all Downtags in a population can be used for PCR amplification and
microarray analysis. YFG stands for Your Favorite Gene. In the case of the HIP for most
annotated yeast genes (Figure adapted from (79)).
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(114)(94). All by this method created YKO mutation contains two 20-nucleotide TAGs
(also called ”molecular barcodes”), which are unique for each deleted gene (Figure 1.12).
The gene-specific Uptag and Downtag are flanked by universal priming sites. In a col-
lection of over 6000 individual deletion strains, each having its own individual Up- and
Downtag, there are over 12000 TAGs. They were designed to be as different from each
other as possible, but retained relatively similar hybridization properties (114)(94). All
of these properties were essential for functional profiling and the genetic manipulation
of the deletion strains as a pool (114)(94)(11)(38)(100). Functional profiling allows
quantitative analysis of the fitness of the deletion strain under a defined condition. All
the strains in the pool can now be analyzed in parallel. By PCR amplifying the TAGs
of the YKO pool before and after applying the selection, genes required to survive the
choosen selection can be identified (Figure 1.13). After hybridization of the TAGs on
a chip the resulting patterns can be used to determine the presence, absence, under-
or over-representation of a particular deletion strain in the population (Figure 1.13).
Mutants that are underrepresented after treatment are identified because they have a
greater TAG signal intensity in the control than in the experiment (94)(11)(100)(65).
Functional profiling of populations using TAG microarrays greatly expedites genetic
screens and makes them intrinsically quantitative.
The bar-coded heterozygous diploid deletion collection is also the basis for the syn-
thetic lethal screen ”dSLAM” (heterozygote diploid-based synthetic lethality analysis
with microarrays) we performed and that will be discussed later in this thesis. The big
advantage is that all approx. 6000 strains can be handled in liquid as a pool and the
query deletion will be introduced in one big transformation in all the strains. Compared
to the ”traditional” SL screen with pinning the non-essential haploid deletion strains
on agar plates and mating them with the query strain harboring the deletion of ”YFG”
in the dSLAM experiment also the essential genes are included and it is possible do
detect synthetic rescue, meaning a second deletion can overcome the lethal phenotype
of a single deletion.
1.3 Phospholipase C
As in this study we show that in yeast PLC1 is a novel synthetic lethal partner with
MHO1 (the yeast homolog of Memo) and Maria et al. (70) showed that Memo Co-
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Figure 1.13: Genetic screen by micro array - Molecular bar-coding facilitates genetic
screens by microarray analysis. The UPTAG and DNTAG ”labels” of each strain enable
numerous YKO mutants to be pooled and analyzed in parallel. Pools of mutants can be
exposed to various conditions or specific selections. Genomic DNA can then be isolated
from YKO pools before and after condition change / selection, and can be used as a PCR
template to amplify the DNTAGs or UPTAGs of the present strains. By using Cy5- (in
red) and Cy3- (in green) labeled universal primers, respectively the number of each YKO
strains in both conditions can be compared. The fluorescently-labeled probes are then
hybridized to an oligonucleotide array. A defective mutant (shown in pink) that did not
survive the induced test condition would only show up in the Cy5 channel. Also a strain
that grows better in the test condition (shown in red) would have a brighter Cy3 signal
compared to Cy 3 or a strain growing slower in the test condition would have a brighter
Cy5 signal compared to Cy3. So from all the ratios of the Cy5 to Cy3 signals the growth
rates of each individual YKO can be determined.
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immunoprecipitates with PLC-gamma1 and Memo regulates heregulin induced PLC-
gamma1 phosphorylation in the next section we will introduce yeast and mammalian
PLC.
In general phospholypases are enzymes which hydrolyzes phospholipids into fatty
acids and other lipophilic substances. Depending on their cleavage site they fall into
different categories (see also Figure 1.14):
• Phospholipase A1 and A1 cleave the fatty acid chains off from the glycerol back-
bone of the phospholipid the at the C1-, C2-Position, respectively.
• Phospholipase B cleaves both ester bond at C1 and C2, it has the activity of
Phospholipase A1 and A2 together.
• Phospholipase C cleaves just before the phosphate group of phospholipids.
• Phospholipase D cleaves just after the phosphate group of phospholipids.
Phospholipase C (PLC) is a conserved gene family found in eukaryotic cells, but
also in bacteria, trypanosomes, and archea. The enzymatic activity for PLC in all
kingdoms of life is always the cleavage of Phosphatidylinositol 4,5-bisphosphate (PIP2)
into the second messengers diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3).
PIP2 is cleaved by PLCs just before the phosphate of the phospholipid, where the
inositoltrisphosphate is bound to the C3-atom of the glycerol backbone (Figure 1.15).
The DAG produced by this reaction the remains bound to the membrane, and IP3 is
released as a soluble structure into the cytosol. Even though PLCs enzymatic activity
is conserved throughout evolution, DAG and IP3 may act differently on cell signaling
depending on the species. In this chapter S. cerevisiae’s unique PLC and the well
studied human PLC isoforms will be discussed.
1.3.1 PLC1 in yeast
In S. cerevisiae the only PLC is encoded by the gene PLC1 (31, 115). The Plc1 protein
consists of an N-terminally PH (Pleckstrin homology)domain, a EF-hand like domain,
a catalytic domain, and a C-terminal C2 domain (75). Yeast Plc1p is structurally most
similar to the mammalian PLCδ isoform (see Figure 1.18) and hydrolyzes phosphatidyli-
nositol 4,5-biphosphate (PIP2) to generate the signaling molecules diacylglycerol (DAG)
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Figure 1.14: Cleavage sites of phospholipases - Cleavage sites of phospholipases.
Phospholipase A1 and A2 cut the esterbond at position C1 and C2 of the phospholipid. The
C1, C2, and C3 positions of the glycerol backbone are indicated in light blue. Phospholipase
C enzymes cut just before the phosphate (light blue circle) attached to the R3 moiety, which
in case of PIP2 is inositol triphosphate. Phospholipase D cuts just after the indicated
phosphate.
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Figure 1.15: PIP2 cleavage by phospholypase C - In the picture the structural
formula of PIP2 is shown and at which position it gets cleaved by PLC. The resulting
DAG and IP3 are also shown as structural formula. IP3 is soluble and gets released to the
cytoplasm whereas DAG remains membrane bound via the two fatty acid side chains.
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and inositol 1,4,5-triphosphate (IP3). IP3 is released from the plasma membrane and
is further processed by four inositol polyphosphate kinases (Ipk2/Arg82, Ipk1, Ksc1,
and Vip1) which then constitute a nuclear signaling pathway that has multiple effects
depending on the produced IPs which influence nutrient sensing, filamentous growth,
nuclear export of mRNA, actin organization, protein synthesis, kinetochore function,
transcriptional regulation, vacuolar fusion, and PKA-mediated stress response (For a
summary see Figure 1.16). However, the exact mechanisms how Plc1 is actively regu-
lated and itself regulates downstream pathways is still mainly unknown. Less is known
for the yeast PLC signaling pathway compared to humans. For example in contrast to
higher eukaryotes yeast has no IP3 receptors on the ER, which after binding regulates
Ca2+ release. The only yeast Protein Kinase C (Pkc1) does have a potential DAG
binding site, but PKC activation is independent of this site as Jacoby et al. (50) have
shown.
The genetic background or the nutrient content of the media can influence the
growth defect of the plc1∆ strains. In some strain backgrounds, the null mutant is
inviable, while in other strains cell growth rate is slightly reduced and lethality is only
seen when grown at higher temperatures. Other plc1∆ phenotypes include extreme
sensitivity to hyperosmotic stress; increased resistance to calcium inhibition; defects
in sporulation; failure to form pseudohyphae under filamentous growth-inducing con-
ditions; increased aberrant chromosome segregation; and, when shifted to higher tem-
peratures arrests as large, multi-budded cells. Affected by PLC1 deletion are amongst
others: transcriptional control (400-500 transcripts are altered by PLC1 deletion), ex-
port of mRNA from the nucleus, homologous DNA recombination, cell death, and
telomere length. In the last years the influence of Plc1 in cAMP/PKA signaling has
becoming more evident. It has been shown that plc1∆ cells accumulate glycogen to a
significantly higher level than wild-type cells indicating a low PKA activity. Consistent
with that finding is that in plc1∆ cells cAMP synthesis following the addition of glucose
is diminished. This result suggests that the lower level of PKA signaling in plc1∆ cells
can be explained by decreased synthesis of cAMP (Figure 1.17. The PKA pathway is
also involved in induction of filamentous growth after Nitrogen depletion.
Little is known about the regulation of PLC1 RNA expression, but consensus bind-
ing sites for the transcription factors Hsf1 and Rap1 have been identified upstream of
the PLC1 gene.
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Figure 1.16: The nuclear IP signaling pathway in Saccharomyces cerevisiae
(Figure adapted from (116)) -
Gpr1
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Figure 1.17: Plc1 regulates the PKA pathway by altering Cdc35 activity -
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1.3.2 Phospholipase C in mammals - from β to ζ
Other than yeast, human cells have several isoforms of PLCs. Human PLCs act as key
proteins in the cellular signaling of many hormones, neurotransmitters, growth factors,
and other extracellular stimuli. PLCs are soluble and cytosolic but some isoforms can
also associate with membranes or interact with G-proteins via their PH domain. PLC-
gamma, in contrast to the other isoforms, can interact with receptor tyrosine kinases
via a SH2 or SH3 domain.
Thirteen kinds of mammalian phospholipase C are known. They are classified into
six isotypes (β, γ, δ, , η, ζ) according to their structure. All PLC isoforms have in com-
mon those structures: a EF-hand domain (has a helix-loop-helix topology in which the
Ca2+ ions are coordinated, this might cause conformational changes that enable Ca2+-
regulated functions and activity (55)), a catalytic domain (cleavage of PIP2 into DAG
and IP3), and a C2 domain (which generally is involved in calcium-dependent phos-
pholipid binding (23)). The PH domain is present in most PLCs (Pleckstrin homology
domain). This domain can bind Phosphatidylinositol lipids within biological mem-
branes like PIP3 or PIP2 (107), and proteins such as the βγ-subunits of heterotrimeric
G proteins (108), and protein kinase C (5).
The mammalian PLC variants are:
• beta: PLCB1, PLCB2, PLCB3, PLCB4
• gamma: PLCG1, PLCG2
• delta: PLCD1, PLCD3, PLCD4
• epsilon: PLCE1
• eta: PLCH1, PLCH2
• zeta: PLCZ1
• The structures of the different isoforms are shown in Figure 1.18.
In mammalian cells PLC cuts Phosphatidylinositol 4,5-bisphosphate (PIP2) into
diacyl glycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG remains bound to
the membrane, where as IP3 is released and diffuses through the cytosol and binds IP3
1.3. PHOSPHOLIPASE C 33
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Figure 1.18: The structures of the different mammalian PLC isoforms and the
yeast only PLC (Plc1) - The four domains of PLCδ, the PH domain, EF-hands (EF),
catalytic domain (containing highly conserved X and Y regions) and the C2 domain (C2)
are also present in most isoforms of other PLC families. The unique region of PLCγ ,
inserted through a flexible loop of the catalytic domain, includes the second PH domain,
two SH2 (Src homology 2) regions and one SH3 (Src homology 3) region. PLCη contains
the domain with a guanyl-nucleotide exchange factor activity (CDC25) and two predicted
RA (Ras association) domains that are implicated in the binding of small GTPases from
the Ras family. In PLCβ, the unique region (tail) is present at the C-terminus. The
sequences unique to PLCζ (tail) are, as in PLCβ, located at the C-terminus. Although
the domain organization of PLCζ resembles that of PLCβ. Yeast has only one PLC (Plc1)
which is most homologous to mammalian PLCδ and expresses the same domains (Figure
adapted from (51)).
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receptors. IP3 receptors are particular calcium channels in the endoplasmic reticulum
(ER). IP3 binding to the IP3 receptors leads to an increase in the cytosolic concentration
of calcium, causing a cascade of intracellular changes and activity, e.g. activating
C2- and EF- domain containing proteins like PLCs. A change of intracellular Ca2+
concentration can regulate many intracellular processes like: enzymatic activity, gene
transcription, synaptic potential in neurons, contraction of muscle fibers, and many
more (3). In addition, the calcium increase and DAG together work to activate protein
kinase C (PKC). Activated PKC then goes on to phosphorylate other molecules, leading
to altered cellular activity. In Figure 1.19 it is shown how the different PLC isoforms
are activated and how downstream signaling is affected. In the following section the
human PLC isoforms β and γ are discussed in more detail. PLC-β is cytoplasmic and
nuclear and it has been shown that Memo influences PLC-γ activation (70).
1.3.2.1 Phospholipase Cβ
Mammalian PLCβ isozymes are differentially distributed in tissues, with the PLCβ1
being most widely expressed, especially in specific regions of the brain. PLCβ1 exists
as alternatively spliced variants β1a and β1b, which differ in their carboxy-terminal
residues (8). In the cytoplasm, PLCβ isozymes function as effector enzymes. They can
activate receptors belonging to the rhodopsin superfamily of transmembrane proteins
that contain seven transmembrane spanning segments. They are activated by a variety
of stimuli and require special combinations of Gα and Gβ/γ subunits to couple to the
effector.
In the nucleus of several cell lines, PLCβ1 is the predominant isoform (24)(68).
For this nucleolar localization the C-terminal has an essential role (53). The first
demonstration came from observations on Swiss 3T3 mouse fibroblasts brought to a
quiescent state and then stimulated with the mitogen insulin-like growth factor-1 (IGF-
1).
1.3.2.2 Phospholipase Cγ
PLC-γ is unique as it is the only PLC isoform expressing a SH2 and SH3 domains.
SH2 (Src Homology 2) and SH3 (Src Homology 3) are small peptide sequences. These
sequences mediate protein tyrosine kinases induced protein-protein interactions in sig-
nal transduction pathways. SH2 domains bind to short phosphotyrosine-containing
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Figure 1.19: Phospholipase C isoforms and Pathways - The PLC family in human
is comprised of 13 subtypes. On the basis of their structure,they have been divided into
six classes,PLC-β (β1,2,3 and 4),PLC-γ (γ 1 and 2),PLC-δ (δ 1,3 and 4),PLC-,PLC-ζ
and PLC-η (η and 2) types. The above described groups vary in many aspects like weight
or how they get activated upon ligand binding of various receptors. Plc association with
membrane receptors which form a positive regulation are best known for the Beta- and
Gamma-type isozymes. In this figure the PLC subtypes are marked with a red arrow and
the greek letter. The hydrolyzation of (PIP2) to generate the signaling molecules inositol
IP3 and DAG by PLCs is highlighted by a red ring and is shown in the middle of the cell
(not at the plasmamembrane).
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sequences in growth factor receptors and other phosphoproteins. SH3 domains bind
target proteins by recognizing a proline and hydrophobic amino acids containing se-
quence.
SH2 and SH3 domain containing proteins, such as Grb2 and phospholipase C
gamma, utilize these modules in order to link receptor and cytoplasmic protein ty-
rosine kinases to the Ras signaling pathway and to phosphatidylinositol hydrolysis,
respectively.
PLC-γ is generally stimulated by growth factors. Due to this it is a prime candidate
for the induction of cell growth and proliferation, although the absolute requirement of
this enzyme for mitogenic signaling is species and cell-type dependent.
Experiments with differential expression of rat brain PLC isoforms in development
and ageing demonstrated showed that PLCγ activity was highest in fetal tissue and
suggested that this isoform was therefore particularly involved in cell division and
growth. In addition to that, PLCγ expression is significantly upregulated in colorectal
and human breast carcinomas compared with normal tissue and is also highly expressed
in a number of colon carcinoma cell lines (77).
Experiments in which wild-type PLCγ1 was overexpressed showed induction of DNA
synthesis and alteration of both the growth rate and the morphology of quiescent fi-
broblasts. Interesting was the finding that lipase-deficient mutants of PLCγ1 can also
induce DNA synthesis in quiescent fibroblasts, although not to maximal levels. Coin-
jection of IP3 and DAG with the lipase-defective PLCγ1 mutant restored maximal
DNA synthesis; thus catalytic activity potentiated the mitogenic response under these
circumstances. This suggests that regions other than the catalytic domain may be
responsible, at least in part, for mitogenic signaling. Further studies in this area have
demonstrated that microinjection of the complete SH domain (two SH2 and one SH3
domain) of PLCγ1 induces a 25-fold increase in DNA synthesis in quiescent fibroblasts,
whereas microinjection of the PH domain had no effect. Fragments of the complete
SH domain, including the two SH2 domains and the SH3 domain preceded by tyro-
sine phosphorylated residues at positions 771 and 783, each induced a partial response.
These responses were additive on coinjection (95). Intriguingly, there is also increasing
evidence from a number of tissues, including VSM, that tyrosine phosphorylation, al-
though undoubtedly necessary, may not always be sufficient to induce full activation of
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PLCγ. Indeed, tyrosine phosphorylation of PLCγ may instead be critical for translo-
cation of the enzyme from the cytosol to the actin cytoskeleton (117). Platelet-derived
growth factor stimulation of fibroblasts results in the localization of tyrosine 783 phos-
phorylated PLCγ1 at membrane ruffles and stress fibers, where it colocalized with
actin filaments. Both this localization and the subsequent depolymerization of actin
filaments can be prevented by injection of both an antibody to tyrosine 783 phosphory-
lated PLCγ1 and by a PLCγ1-2SH2 domain protein. Intriguingly, microinjection of a
13-amino acid phosphorylated peptide, containing tyrosine 783 alone, can also induce
disassembly of actin filaments and membrane ruffling in fibroblasts, suggesting that
catalytic activity is not necessary for actin rearrangement (Figure 1.20). In accordance
with these studies, the introduction of a mutant PLCγ1 in which phenylalanine had
been substituted for tyrosine at position 783 resulted in cells taking on a different mor-
phology from those expressing wild-type PLCγ1, exhibiting both much thicker actin
filaments and reduced DNA synthesis (82).
Clearly then, PLCγ isoforms are implicated in mitogenic signaling, with a major
role of these isoforms being the reorganization of the actin cytoskeleton, which can
occur independently of the catalytic activity of this enzyme.
1.4 Nuclear import and export
The most prominent feature of eukaryotic cells compared to procaryotic cells is the
presence of a nucleus, which is defined by the nuclear envelope (NE). The NE physi-
cally separates nuclear DNA from the cytoplasm. This membrane specially devides the
sites of gene transcription and ribosome biogenesis from the site of protein synthesis.
This compartmentalization allows the cell to strictly coordinate numerous key cellular
processes, it requires a efficient shuttling system of proteins and RNAs between nucleus
and cytoplasm. To understand the mechanisms that drive nucleo-cytoplasmic trans-
port pathways, and how they influence cell growth, numerous studies have focused on
unraveling the web of physical interactions that facilitate transport (reviewed in (32)).
1.4.1 Nuclear import
In the nucleus most of the genetic information is stored. Because transcription is local-
ized to the cytoplasm and translation takes place in the nucleus the two actions are kept
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Figure 1.20: signaling through PLCγ1 without production of IP3 and 1,2-
diacylglycerol (DAG) - The figure shows a schematic depicts effects of complete SH
domain of PLCγ1. Between the 2 SH2 domains and the SH3 domain the two Tyr residues
Tyr771 and Tyr783 are shown. Upon their phosphorylation PLCγ1 can co-localize with
actin and induce/support actin disassembly which itself can control transcription, e.g via
MRTF (myocardin-related transcription factors) and SRF (serum response factof) (re-
viewed in (78, 85)).
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apart from each other by a double lipid bilayer also known as the nuclear envelope (NE).
The nuclear envelope is composed of an inner and an outer nuclear membrane (INM and
ONM). To allow material transport between the two compartments the INM and ONM
are cross-linked at well defined points by large macromolecules. These macromolecules
form a pore through the two membranes which are known as the nuclear pore complex
(NPC). This setup allows only transport through the NPC to shuttle material between
nucleus and cytoplasm. The NPC is not a simple channel, but can selectively import
or export macromolecules across the two membranes and act as a semi-permeable fil-
ter (reviewed in(101)). Accordingly, proteins smaller than approx. 40 kDa can freely
diffuse through the NPC, while larger proteins are actively transported through the
NPC. That directed transport is organized by dedicated nuclear transport receptors
of the β-karyopherin family, which includes at least 20 different known importins and
exportins in humans (74).
1.4.1.1 Classical NLS (Nuclear localization sequence)
Importins can recognize protein that must be actively imported to the nucleus from the
cytoplasm because they carry a nuclear localization signal (NLS). A NLS is a sequence
of amino acids that acts as a tag (73). The NLS can vary in the Aa composition but
are most commonly hydrophilic, although hydrophobic sequences have also been found
to act as NLS (14).
Importins bind their cargo protein (targeted into the nucleus) in the cytoplasm.
The importin-cargo complex is able to interact with the NPC and pass through its
channel. Arrived inside the nucleus the interaction of the complex with Ran-GTP
causes a change in the conformation in the importins. This conformational change
causes the dissociation of the cargo proteins. The newly formed complex of importin
and Ran-GTP then recycles back to the cytoplasm (reviewed in (41)) (Figure 1.21).
1.4.2 Nuclear export
In general terms the reversion of nuclear import is the nuclear export. In the nucleus
exportins bind the cargo (proteins to be exported) having the appropriate signal se-
quence and Ran-GTP. The now formed complex gets transported through the nuclear
pore into the cytoplasm. In the cytoplasm the complex dissociates. Ran-GTP binds
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Figure 1.21: Nuclear Import and Export - The recognition of the classical nuclear lo-
calization signal (NLS) of the protein to be imported (Protein X) by importin-α (Imp-α) ini-
tiates the process of nuclear import. Importin-aα subsequently dimerizes with importin-β
and localizes to the nuclear envelope where it binds Ran-guanosine diphosphate (RanGDP)
and docks at the nuclear pore. After passing the nuclear pore the importin complex dis-
sociates and releases its cargo into the nucleus.The imprtins α and β get recyled back to
the cytoplasm. In nuclear export, the exportins (Expor.) recognizes proteins containing
leucine-rich nuclear export signals (NESs) (in this figure Protein Y). For nuclear export
the GTP-bound form of Ran (RanGTP) is required. Export complex formation is favored
by high concentrations of RanGTP in the nucleus, which facilitates translocation through
the central channel of the nuclear pore complex. Upon passing the nuclear pore and arrival
in the cytoplasm, the export complex is disassembled and cargo released.
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GAP and the GTP get hydrolyzed, the resulting Ran-GDP recycles back into the nu-
cleus where it exchanges its bound ligand for GTP and the cycle can restart. This
means that importins depend on RanGTP to dissociate from their cargo, where as
exportins require RanGTP in order to bind to their cargo (84) (Figure 1.21).
To efficiently export newly formed mRNA from the nucleus there is a specialized
mRNA exporter protein. After post-transcriptional modifications are completed the
mature mRNA gets actively exported by this complex. This translocation process
depends on the Ran protein, although the exact mechanism how mRNA export is reg-
ulated is not yet fully understood. Some particularly commonly transcribed genes are
physically located near nuclear pores to facilitate the translocation process (reviewed
in (20)).
1.4.2.1 NES (Nuclear export sequence)
Other than the NLS the nuclear export signal (NES) is not as clear defined. The NES
consists of a short Aa sequence of 4 hydrophobic residues. The exportins recognize this
residues and bind them. The exportin-cargo-complex then shuttles the cargo from the
nucleus to the cytoplasm through the nuclear pore complex. A NES has the opposite
effect of a NLS. In silico analysis of known NESs found the most common spacing
of the hydrophobic residues to be LxxxLxxLxL, where ”L” is a hydrophobic residue
(often leucine) and ”x” is any other amino acid. A explanation for the spacing of the
hydrophobic residues may give examinations of known structures that contain an NES.
Usually the critical residues lie on the same side of a protein to facilitate the interaction
with the exportins (60).
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2Aims of the project
2.1 Phenotypic and functional analysis of the MEMO ho-
molog in Saccharomyces cerevisiae MHO1 by using
screening techniques to place it in a pathway / Does
yeast MEMO have a role in actin and/or microtubule
dynamics?
Memo was found to be a novel ErbB2 P-Y binding protein which has a role in ligand
induced actin and microtubule depended migration. As Memo is highly conserved in
evolution and is also found in Saccharomyces cerevisiae, we wanted to use this well
studied model organism to elucidate the function of Memo.
To answer this question we used major large scale screen techniques and genetic
manipulations in yeast to find a phenotype for Memo deleted cells. We did two different
synthetic lethal screens, we tried TAP-tag purification to find binding partners of Memo,
and we also did micro-arrays. But not only large scale screens were used, we also
took advantage of the genetic manipulation which are better studied in yeast than in
mammalian cells.
2.2 MEMO nuclear localization in mammalian and yeast
cells
During this work it became evident that not only the yeast Memo protein localizes to
the nucleus, but also the mammalian protein is manly found in the nucleus. Confocal
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microscopy analysis in quantification of signal intensity in SKBR3 cells labeled for
Memo showed that more than 60% of Memo protein is nuclear independent if the cells
are starved, grown in full medium or induced with HRG (heregulin). Upon stimulation
of the cells with the appropriate factors Memo is also found at the plasma membrane
but no conditions are known where it completely leaves the nucleus. We then focused
on the questions how the localization of Memo is controlled and if nuclear localization
is essential for the function of the protein.
2.3 Could MEMO be an enzyme?
The 3D structure of Memo has been solved and it shows high similarity to a Lig B sub-
unit of LigAB is a class III nonheme iron(II)-dependent extradiol-type catechol dioxy-
genase found in Sphingomonas paucimobilis. Even though the amino acid sequence
homology is low (15%) most of the amino acids that are essential for the dioxygenase
function (see Figure 2.1)are also present in all Memo protein found in all kingdoms
of live. The obvious question we addressed was then, does Memo have a dioxygenase
activity? And if not, could this conserved protein still be an enzyme?
Figure 2.1: Stereo image of a superposition of the LigB active site residues
with the homologous residues in Memo. - Memo residues are colored blue, and LigB
residues are colored yellow. The E242 from LigB is not present in Memo. Memo has the
C244 which coordinates to that specific position. (Figure from (89)).
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3.1 Abstract
The novel protein Memo (Mediator of ErbB2 driven cell motility) was identified in a
screen for ErbB2 interacting proteins and found to have an essential function in cell
motility. Memo is evolutionarily conserved with homologs found in all branches of life;
the human and yeast proteins have a similarity of > 50%. In the present study we used
the model organism S. cerevisiae to characterize Mho1 (Yjr008wp) and to investigate its
function in yeast. In a synthetic lethal screen we found MHO1 as a novel synthetic lethal
partner of PLC1, which encodes the single phospholipase C in yeast. In the absence of
MHO1 and PLC1, double-deleted spores germinate, but their proliferation is impaired.
Introduction of human Memo into the memo∆plc1∆ strain rescued the synthetic lethal
phenotype suggesting that yeast and human proteins have similar functions. Mho1 is
present in the cytoplasm and the nucleus of yeast cells; the same distribution of Memo
was found in mammalian cells. None of the Memo homologues have a characteristic
nuclear localization sequence, however, a conserved nuclear export sequence is found
in all. In mammalian cells, blocking nuclear export with Leptomycin B led to nuclear
Memo accumulation, suggesting that it is actively exported from the nucleus. In yeast
MHO1 expression is induced by stress conditions. Since invasive growth in S. cerevisiea
is also stress-induced, we tested Mho1s role in this response. MHO1 deletion had
no effect on invasion induced by nutrient deprivation, however, Mho1 overexpression
blocked the invasive ability of yeast cells, suggesting that Mho1 might be acting in a
dominant negative manner. Taken together, our results show that MHO1 is a novel
synthetic lethal interactor with PLC1, and that both gene products are required for
proliferation. Moreover, a role for Memo in cell motility/invasion is conserved across
species.
3.2 Introduction
Memo (Mediator of ErbB2 driven cell motility) was identified in a screen for ErbB2
receptor tyrosine kinase (RTK) interacting proteins with roles in cell motility. Memo
specifically interacted with a phospho-peptide encompassing an autophosphorylation
site in the C-terminus of ErbB2. Treatment of tumor cells with the ErbB2 activating
ligand heregulin (HRG) induces migration and in siRNA-mediated Memo knock-down
(KD) cells, HRG-induced migration is dramatically impaired [1,2]. Memo is encoded
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by a gene found in all kingdoms of life, and multiple sequence alignment showed that
the protein sequence is highly conserved. Memo has no obvious functional domain
and does not belong to a known protein family. Interestingly, Memo is structurally
homologous to a LigB, a non-heme iron binding dioxygenase [3], however, Memo lacks
an essential glutamate that is present in all LigB family members, making it unlikely
to be a functional dioxygenase [3]. The yeast gene YJR008W shows more than 50%
similarity with the human gene and was named MHO1 (Memo HOmolog 1). In the
present study, we investigated the function of Mho1 (Yjr008wp) in S. cerevisiae. We
show here that MHO1 is a novel synthetic lethal (SL) interactor with PLC1. Yeast cell
germinate in the absence of both genes, however, they cannot proliferate. Moreover,
we found that under conditions of nutrient insufficiency Mho1 plays a role in haploid
invasive growth. This suggests that a function for Memo in cell motility/invasion
appears to be conserved across species
3.3 Results
3.3.1 MEMO is a single copy gene conserved throughout evolution
To identify MEMO homologs in other sequenced organisms, we performed a blastp
search (Basic Local Alignment Search Tool), using the blastp tool provided from NCBI
(as described in [4]), and the human Memo protein sequence as query. One copy
of a MEMO homolog was found in various species representing all kingdoms of life
(Figure 3.1 A). By performing multiple sequence alignments we could show that Memo
is highly conserved. The human and the yeast protein share an identity of more than
40% and a similarity of more than 50%. Some amino acids are completely conserved
from bacteria to human; in particular those close to the predicted vestigial active site
of Memo (indicated in red, Figure 3.1 B). This suggests that these amino acids could
be essential, for example, for a potential enzymatic activity, or as part of a novel
conserved binding domain. The yeast gene, YJR008W, was named MHO1 (Memo
HOmolog 1). In this paper the human gene and protein are referred to as MEMO and
Memo, respectively; the yeast gene and protein are referred to as MHO1 and Mho1,
respectively.
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3.3.2 Examination of effects of MHO1 deletion in S. cerevisae
MHO1 was deleted in the wild-type strains BY4741, BY4742, and BY4743 [5] by
standard methods. The deletion of MHO1 in haploid or diploid cells had no effect on
viability, nor did it affect growth in liquid culture at 20C, 30C, and 37C. The mho1∆
cells were also tested for their sensitivity to various agents including hydroxyurea (HU),
NaCl, CoCl2, rapamycin, and benomyll. No difference in growth was observed in
mho1∆ cells compared to the wild-type cells (Figure S3.8).
Memo is required for migration to tumor cells in response to activation of vari-
ous RTKs and Memo KD impacts on the actin and microtubule (MT) cytoskeleton
[1,2]. Accordingly, we investigated if Mho1 has a role in yeast motility and cytoskeletal
morphology. To visualize the MTs, we used a yeast strain expressing a copy of TUB1-
GFP using the plasmid pAFS125 [6]. MHO1 deletion was introduced into this strain
by replacement with the klTRP1 selection marker. Using fluorescent microscopy, we
observed no difference in the microtubule cytoskeleton between wild-type and mho1∆
strains (Figure 3.2 A). The actin-containing structures (reviewed in [7]) were also ex-
amined by microscopy. Neither the cortical actin patches, nor the actin cables differed
between the wild-type and mho1∆ strains (Figure 3.2 B, 1 and 2, respectively,); actin
rings or actin at the site of polarized growth were also unaffected by Mho1 loss. Thus,
Mho1 is not required to maintain normal actin or MT cytoskeletal structures.
3.3.3 The deletion of MHO1 in fungal species does not affect polarized
growth
To investigate if Mho1 has a role in polarized growth in fungi, we used the well-studied
model organism Asbya gossypii [8], a filamentous growing ascomycete. Since filaments
can grow at 200µm/h, A. gossypii requires sustained polarisation at the growing tip;
crucial is the interplay between the actin cytoskeleton, microtubules, and proteins in-
volved in polarised growth [9,10]. The A. gossypii homolog gene is AGR321W, which we
will refer to as MHO1, for simplicity. The A. gossypii MHO1 deletion strain was gener-
ated by standard means [11]. The mho1∆ strain was viable and sporulation efficiency
and spore morphology were identical to the wild-type strain. Four actin structures
are well defined in A. gossypii : 1) cortical actin patches along the entire hypha, 2)
actin patches at the tip, 3) actin rings at the site of septation, and 4) actin cables. In
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Phalloidin-FITC labelled cells, all four structures were indistinguishable between the
wild-type and the mho1∆ strain (1-4, respectively, in Figure 3.3A). We also measured
radial growth speed after inoculating a few spores on an agar Petri dish containing
full medium. Both wild-type and mho1∆ strains covered the entire plate within seven
days (Figure 3.3B). No differences in growth speed, hyphal morphology or branching
patterns were observed.
A. gossypii always uses filamentous growth; there is no switch from isotropic to
polarized growth in response to external stimuli or changes in growth conditions. Thus,
we also investigated the role of Mho1 in the S. cerevisiae mating response. In order to
mate, haploid cells recognize pheromone of the opposite mating type cell and extend a
shmoo towards the pheromone gradient (reviewed in [12]). Deletion of MHO1 had no
effect on the elongation of a hyphal-like structure in S. cerevisiae (Figure 3.3C) and
mating efficiency was similar to wild-type.
3.3.4 Mho1 is present in the nucleus and the cytoplasm
To follow Mho1 sub-cellular localization, the endogenous protein was tagged at its
C-terminus with GFP, by standard methods [13]. Mho1-GFP expressing cells were
grown to stationary phase, since Mho1 expression is up-regulated under these conditions
(Figures S3.9 and S3.10), and its localization was examined by fluorescent microscopy.
Mho1-GFP was found in the cytoplasm and the nucleus; no GFP signal was detected
in the vacuole (Figure 3.4A, labelled c, n and v, resp.). Although Mho1 expression
levels are lower in log-phase cells, a similar distribution was observed. To examine the
localization of the human Memo in yeast, we cloned the GFP-tagged hMEMO gene into
an integrative plasmid, which was integrated into the TRP1 locus. hMEMO expression
was induced by galactose and GFP was visualized. Human Memo-GFP has a similar
distribution as the yeast protein, and is present in cytoplasm and nucleus, but not in
the vacuole (Figure 3.4B).
Memo localisation was also examined by immunofluorescence (IF) in mammalian
cells using a Memo-specific specific antibody [1]. IF for Memo carried out on mouse
embryonic fibroblasts (MEFs) revealed cytoplasmic and nuclear staining, with exclusion
from the nucleoli (Figure 3.4C). IF for Memo in SKBR3 breast tumor cells revealed
that in growth medium containing 10% fetal calf serum, Memo was distributed in the
cytoplasm and the nucleus (Figure 3.4D, left panel). In response to ErbB2 activation,
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in HRG-treated cultures, the cytoplasmic Memo is strongly localized at the plasma
membrane and appears enhanced in the nucleus (Figure 3.4D, right panel). However,
quantification of the images did not reveal any significant differences in nuclear Memo
in the two conditions. Thus, the human and the yeast protein are localized to similar
sub-cellular compartments.
3.3.5 Memo is actively exported from the nucleus
Although Memo and Mho1 were present in the nucleus of yeast and mammalian cells,
neither protein has a nuclear localization signal (NLS). However, a consensus nuclear
export sequence (NES), LxxxLxxLxL (L= Leucine or hydrophobic amino acid and X
= any amino acid), was identified in both proteins and was found to be conserved
throughout evolution (Figure 3.5A). Using the 3D protein structure of Memo [3] as a
model, the NES is located between β-sheet 2 and α-helixC on an approximately 15
residue loop on the surface of the protein (red ribbon in Figure 3.5B).
The 33 KDa Memo could diffuse through the nuclear pore, but might also be actively
imported and/or exported from the nucleus. To test this, we used SKBR3 human
breast tumor cells and examined the effects of HRG and the nuclear export inhibitor
Leptomycin B [14] on Memo distribution. IF revealed that there was no significant
difference between nuclear Memo levels in the control compared to the HRG treated
cultures (Figure 3.5C, panel A vs. B), confirming the results shown in Figure 3.4D.
To block export, SKBR3 cultures were treated overnight with 60 ng/ml Leptomycin
B, then were either left untreated or were exposed shortly to HRG. Compared to the
control cells in 10% FCS, there was a significant accumulation of nuclear Memo in
the Leptomycin B treated SKBR3 tumor cells (Figure 3.5C, panel A vs C). Moreover,
after 20 min of HRG treatment, there was a further increase in nuclear Memo in the
Leptomycin B treated cultures (Figure 3.5C, panel C vs D). These results suggest that
Memo might enter the nucleus passively, either alone or in a complex, but once in the
nucleus Memo is actively exported.
3.3.6 MHO1 is synthetic lethal with PLC1
To further analyze Mho1 function, we performed a SL screen in S. cerevisiae. A MHO1
deleted strain was made and mated with each of the 4800 viable haploid deletion strains.
The only strain that showed a SL phenotype with MHO1 deletion was PLC1 deletion,
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the gene encoding the single isoform of phospholipase C found in yeast. To verify
these results, we examined the growth of the wild-type strain and strains individually
and double- deleted in MHO1 or PLC1. This was accomplished by constructing Matα
mho1::natMX and Mata plc1::kanMX strains, which were mated and sporulated. The
dissected spores were then tested for growth on YPD plates plus G418 or ClonNat. Only
wild-type cells, and mho1∆ or plc1∆ deleted cells could grow; none of the double-deleted
cells grew (highlighted in Figure 3.6A with a white circle). It should be mentioned that
the plc1∆ colonies are smaller since the deleted cells grow more slowly. In summary,
the SL interaction between MHO1 and PLC1 uncovered in the large scale screen, could
be verified.
Next, we analyzed if the SL phenotype is due to a germination defect or if it occurs
in proliferating cells. For this, we cloned the PLC1 gene including its endogenous pro-
moter and terminator in a CEN/ARS plasmid with the URA3 selection marker (Figure
3.6B), and introduced it into the plc1∆ cells. After mating with the mho1∆ strain and
subsequent sporulation, the wild-type, mho1∆, plc1∆, and mho1∆ plc1∆ stains, each
with the pRS416 PLC1 plasmid, were isolated. After plating on 5-Fluoroorotic acid
(5-FOA), which selects for loss of the URA3 marker, all but the double-deleted strain
grew (Figure 3.6C). Once the double-deleted cells loose the Plc1p expression plasmid,
the cells stop proliferating. This experiment shows that Mho1 and Plc1 are not required
for sporulation, but are needed for proliferation.
3.3.7 Human MEMO can replace MHO1 and rescue the SL pheno-
type with the plc1∆ strain
The yeast and the human gene share a similarity of ¿ 50% (Figure 1A). We tested
if human MEMO can complement the function of the yeast gene in plc1∆ cells by
replacing the yeast gene with the human gene. By mating the mho1::hMEMO natMX
strain with a plc1::kanMX strain and dissecting spores, we could show that haploid
strains carrying both selection markers grew. These results demonstrate that human
Memo can replace the yeast protein and rescue the SL phenotype with plc1∆ (Figure
3.6D).
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3.3.8 Mho1 overexpression blocks haploid invasive growth
A large-scale screen examining the effects of gene disruption and overexpression on
alcohol-induced filamentous growth uncovered Mho1 as having a potential function in
this stress-induced process [15]. Not only alcohol, but other growth conditions in-
cluding nutrient deprivation induce filamentous growth [16]. Under these conditions
a haploid strain extends invasive filaments downward, which is referred to as haploid
invasive growth [17]. Thus, we tested if Mho1 expression levels influenced haploid in-
vasive growth in conditions of nutrient insufficiency. For this, Mho1 overexpression
and deletion strains were made in the haploid invasive wild-type yeast strain Σ1278B
[18]. Two deletion strains (Σ1278B mho1::kanMX and Σ1278B mho1::URA3 ) and two
overexpression strains (Σ1278B MHO1::OE and Σ1278B His-MHO1::OE ) were con-
structed (Figure 3.7A). To verify overexpression in response to galactose, extracts from
Σ1278B His-MHO1::OE were tested in a western analysis using a His specific antiserum
to detect Mho1. Only the extracts from cells grown on galactose showed high levels of
His-Mho1 (Figure 3.7B).
To monitor invasive growth, the deletion and overexpression strains as well as con-
trol strains were streaked on YPD or YPGal plates, incubated for four days, and then
washed with tap water to assess invasive potential. The deletion of Mho1 did not in-
fluence the invasion of the cells into the agar in any of the growth conditions (Figure
3.7C). In contrast, on the Gal plates, the two strains overexpressing Mho1 (Σ1278B
MHO1::OE and Σ1278B His-MHO1::OE ) failed to invade (Figure 3.7C). Taken to-
gether, the results suggest that while Mho1 is not essential for invasive growth, abnor-
mal levels of the protein impede the process.
3.4 Discussion
Memo is evolutionarily conserved with homologs found in all branches of life. Memo
was initially identified based on its importance in breast cancer cell motility in response
to ErbB2 activation [2], where it was shown to have an essential role in promoting the
directionality of motile cancer cells [1]. The human and yeast proteins have a similarity
of ¿ 50% and in the work presented here we used S. cerevisiae to characterize Mho1,
the yeast homolog. We uncovered a role for Mho1 in haploid invasive growth, which
might be linked to its function in mammalian cells, suggesting that this activity is
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conserved across species. Moreover, we uncovered a novel function for Mho1, namely a
synthetic lethal interaction with PLC1. To date the genes that have been identified as
SL with PLC1, BUB1, BUB3 and CBF1, have roles in spindle-assembly checkpoint and
damage (Supplemental Table 3.4); Mho1 has not been implicated in these processes.
We show here that yeast cells germinate in the absence of PLC1 and MHO1, however,
they cannot proliferate.
Based on the importance of Memo in mammalian cell motility, we expected to find
a role for Mho1 in yeast MT and/or actin dynamics. However, we were unable to
uncover any differences between mho1∆ cells and wild-type cells. Neither the MTs nor
the actin-containing structures in proliferating S. cerevisiae were abnormal in mho1∆
cells. Moreover, the filamentous ascomycete A. gossypii, which requires coordinated
interactions between the actin and the MT cytoskeleton for growth, was not affected
by MHO1 deletion. However, we noticed during our studies that Mho1 levels increased
as cells reached stationary phase. A search of publicly available data bases, revealed
that MHO1 RNA expression is induced 5-fold or more in stationary phase and other
stress conditions [19] (Supplemental figures 3.9 and 3.10). While mho1∆ cells behaved
similarly to wild-type cells in many of the stress conditions, we found that nutrient-
deprived stress-induced haploid invasive growth was blocked in the presence of high
Mho1 levels. Since mho1∆ cells were not impaired in haploid invasive growth, these
results suggest that overexpressed Mho1p behaves in a dominant negative fashion. In
summary, the results suggest that Mho1 might not have an essential role in normal
cellular situations, but in a stress condition related to migration/invasion Mho1 levels
need to be maintained at physiological levels for a normal response.
A large set of genes (approximately 900) showed a similar response to most of the
environmental changes that induce MHO1 expression [19]. Promoter analysis and sub-
sequent characterization of the responses of strains mutant for some of these genes im-
plicated the transcription factors Yap1, Msn2p and Msn4p in mediating the transcrip-
tional response [19]. We analysed the promoter region of MHO1 to find binding sites
for transcription factors and uncovered potential sites for Msn2/Msn4 and Ino2/Ino4
(Supplemental Figure 3.11A). MSN4 gene expression is itself Msn2/4p dependent and
induced by stress, while MSN2 expression is constitutive [19]. By consulting the data
base from YEASTRACT (Yeast Search for Transcriptional Regulators And Consensus
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Tracking) [20] we found additional TF that could potentially directly or indirectly affect
MHO1 transcription (Supplemental Figure 3.11B).
In the SL screen we found MHO1 as a novel SL partner of PLC1. Introduction
of human Memo into the memo∆plc1∆ strain rescued the SL phenotype suggesting
that yeast and human proteins have similar functions. The mechanism underlying
the SL interaction is not currently known, however, it is interesting to discuss some
possibilities. Plc1p hydrolyzes the membrane phospholipid PtdIns(4,5)P2 to produce
1,2 diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). In mammalian cells,
DAG is needed for activation of some PKC isoforms. In yeast, C1, the potential DAG
binding domain of Pkcp, is not required to restore viability to pkc∆ cells, suggesting that
Pkcp is not involved in the SL phenotype. Moreover, in yeast multiple pathways provide
DAG, making it unlikely that low DAG levels are responsible for the SL interaction
with MHO1. We had a closer look downstream of IP3, the precursor to IP4, IP5 and
IP6. These phospholipids control many processes in yeast cells, such as nuclear mRNA
export [21] and chromatin remodeling [22]. (For a full list of activities see Supplement
Figure 5). To examine the involvement of this pathway in the SL phenotype, we
tested if MHO1 is SL with ARG82/IPK2, IPK1, KCS1 or VIP1, the four inositol
polyphosphate kinases downstream of Plc1. All of the double-deleted strains were
viable and grew similarly to memo∆ cells, suggesting that none of the other InsPs are
involved in the SL phenotype with MHO1. Thus, we can only speculate that IP3 has
an activity outside of its role as a precursor to the other InsPs and that this is required
for proliferation in the memo∆ cells.
The SL phenotype uncovered in yeast is particularly intriguing since one of the
mammalian PLC isoforms, PLCγ1, was identified in the same screen that uncovered
Memo; PLCγ1 associated with a different ErbB2 autophosphorylation site [1]. Indi-
vidual knock-down of either Memo or PLCγ1 impaired directed cell motility and si-
multaneous KD of both proteins totally blocked migration [2]. Since the memo∆plc1∆
strain failed to proliferate, it was not possible to test for effects on migration. However,
both proteins do have roles in invasion/migration. Plc1p is essential for the activity of
a nitrogen-controlled signaling pathway that controls pseudohyphal growth, and as we
show here, Mho1 overexpression blocks haploid invasive growth.
The fact that Memo is structurally homologous to a bacterial class of dioxygenases,
makes it tempting to speculate that Memo might have enzymatic activity. However, as
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mentioned in the Introduction, it is unlikely to have the same activity as the bacterial
LigB family. Our current working hypothesis is that Memo is an enzyme, which might
have acquired additional cellular activities during evolution, one being to serve an
adaptor function. Indeed, in SKBR3 breast tumor cells, it was recently shown that
Memo controls the association of RhoA and its effector mDia with the plasma membrane
in response to ErbB2 activation, thereby impacting on recruitment of actin-binding
proteins, MT dynamics [23] and migration [2]. These results suggest that Memo might
be acting as an adaptor to localize proteins (and their activity) to specific cellular sites
in order to initiate biological responses, in this case motility. The fact that Memo is also
present in the nucleus, suggests that it might also have activities in this compartment.
Future work will be aimed at uncovering the other roles of Memo and identifying its
putative enzymatic activity.
3.5 Materials and methods
3.5.1 Strains and Media
For a complete list and genotypes of yeast strains used in this work, see Tables 3.1
and 3.2. For experiments with S. cerevisiae most strains are congenic with BY4741
BY4742, and BY4743 wild-type strains. The haploid and diploid bar-coded systematic
deletion collections for nonessential genes are in the strains BY4741 and BY4742 and
BY4743, respectively. These were purchased from Invitrogen. For filamentous growth
and invasion assays the yeast strain Σ1278B was used (kindly provided by P. Jenoe,
Biocenter, Basel). All deletion strains were made by PCR mediated homologous re-
combination using the kanMX [23] or the natMX [24] selection. Transformation of the
yeast strains was done using the LiAc/SS Carrier DNA/PEG method as described [25].
The A. gossypii strains were constructed by PCR-based gene targeting as described [11]
and were cultured as described [26]. Actin staining with Alexa Fluor 488 (Molecular
Probes, Eugene, OR) was done as described [27].
3.5.2 DNA Manipulations, Plasmids and Strain Constructions
We applied a PCR-based method to construct gene deletion cassettes that were used
in yeast transformations [24]. All deletion strains were made by using the kanMX [24],
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the natMX [25], the URA3MX [29] or the klTRP1 [30] deletion cassettes. Transfor-
mation of the yeast strains was done using the LiAc/SS Carrier DNA/PEG method
as described [26]. Correct genomic integration of the corresponding construct was
verified by analytical PCR [24]. Yeast strains were grown on: YPD-G418 (200 mg/l
geneticin) to select for transformants that had integrated kanMX deletion cassettes; or
on YPD-CloNat (100 mg/l nourseothricin) to select for transformants that had inte-
grated natMX deletion cassettes. To replace the yeast gene with the human gene, the
humanMEMO-natMX cassette was integrated. Growth on SD plates lacking uracil or
tryptophan selected for transformants that had integrated URA3MX deletion cassettes,
selected for the integration of the uptake of the plasmid pRS416, or klTRP1 integra-
tion. Yeast strains were grown on YPD-5-FOA plates (100 mg/l 5-Fluoroorotic Acid)
for selecting cells that have lost the URA3 carrying pRS416 plasmid. The plasmids
used in this work are listed in Table 3.3.
3.5.3 Generation of Mouse Embryonic Fibroblasts (MEFs)
Mouse embryonic fibroblasts (MEFs) were generated by standard procedures from
Memo fl/fl embryos and were spontaneously immortalized by continued passaging in
Dulbeccos modified Eagles medium (DMEM) supplemented with 10% Fetal Calf Serum
(GIBCO Invitrogen AG, Basel, Switzerland) and Penicillin and Streptomycin (growth
medium).
3.5.4 Microscopy
For yeast microscopy we used an Axioimager Z1 microscope (Carl Zeiss, Feldbach,
Switzerland), equipped with a X-Cite 120 EXFO Metal Halide for fluorescence and
Halogen for TL, a motorized XYZ stage, and a Plan-APOCHROMAT 100x/1.4 DIC
Oil objective. GFP/Alexa488 (Zeiss #10) and DAPI (Zeiss #49) filter sets were used
(Carl Zeiss, Feldbach, Switzerland). Fluorescence excitation was controlled by a shutter
controller. We used a AxioCam MRm (1388 x 1040 pixels, Pixel size 6.45 ?m) back-
illuminated, cooled charge-coupled device camera mounted on the primary port. We
used the AxioVision software from Zeiss for data acquisition, processing and analysis.
SKBR3 cells (ATCC, Manassas, Virginia) were grown on glass coverslips (BD Bio-
sciences, San Diego, CA) coated with 25 ug/m rat-tail collagen I (Roche Diagnostics)
and MEFs were grown on µ-Slides 8well from ibidi (Martinsried, Germany), in DMEM
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containing 10% FCS at 37C and stimulated with 10 nM HRG for 20 minutes. Cells
were fixed with 4% paraformaldehyde and 3% sucrose in PBS, permeabilized in 0.2%
Triton X-100 in PBS, and blocked with 1% BSA in PBS before incubation with the
primary rat anti-?-tubulin antibody and mouse anti-Memo antibody. Alexa-Fluor 546
conjugated anti-rat antibody (Molecular Probes, Eugene, OR) and Alexa-Fluor 488
conjugated anti-mouse antibody (Molecular Probes, Eugene, OR) were used as sec-
ondary antibodies. F-actin was stained at room temperature with 2 U/ml FITC-labeled
phalloidin (Molecular Probes, Eugene, OR). Cells were washed with PBS-Tween 0.1%
and mounted with a mounting solution (ProLong Gold Antifade Reagent, Molecular
Probes). Mounted samples were examined using Axioimager Z1 microscope (Carl Zeiss,
Feldbach, Switzerland) or using the Laser Scanning Microscope Axio Imager Z2 with
the LSM 700 scanning head. Pictures from MEFs were taken with the following equip-
ment: The Axioimager Z1 microscope (Carl Zeiss, Feldbach, Switzerland) was equipped
with a X-Cite 120 EXFO Metal Halide for fluorescence and Halogen for TL, a motorized
XYZ stage, and a Plan-APOCHROMAT 100x/1.4 DIC Oil objective. GFP/Alexa488
(Zeiss #10) and DAPI (Zeiss #49) filter sets were used (Carl Zeiss, Feldbach, Switzer-
land). Fluorescence excitation was controlled by a shutter. We used a AxioCam MRm
(1388 x 1040 pixels, Pixel size 6.45 µm) back-illuminated cooled charge-coupled device
camera mounted on the primary port. We used the AxioVision software from Zeiss
for data acquisition, processing and analysis. Pictures from SKBR3 cells were taken
with the following equipment: Axio Imager Z2 with the LSM 700 scanning head was
equipped with the Laser lines: 405 (5mW), 488 (10mW), 555 (10mW), 639 (5mW);
and the Lights: Coolled 405, 490, 565 (RL), Halogen (TL), a motorized XYZ stage,
and the objectives: Plan-Apochromat 20x/0,8 M27;?EC Plan-Neofluar 40x/1,30 Oil
M27;?Plan-Apochromat 63x/1,40 Oil DIC M27. The Axio Imager Z2 had 2 Epifluores-
cence PMTs and 1 Transmission PMT. For acquisition we used the ZEN2010 software
from Zeiss. Data were further processed and analyzed with Imaris from Bitplane Sci-
entific Software (Zurich, Switzerland).
3.5.5 Signal intensity quantification
Z-stack Images taken with the Axio Imager Z2 with the LSM 700 scanning head were
analyzed with ZEN2010 software and 3D image reconstruction was processed with
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IMARIS software (Bitplane AG, Zurich, Switzerland). In order to determine the nu-
clear intensity of the Memo staining, nuclear surfaces were created using the automatic
threshold and pixels from this area were extracted from the total surface area to create
the cytoplasmic surface. The mean intensities from these two surfaces were then mea-
sured. The mean differences in starved cells were compared to those in treated cells
using the Students t-test.
3.5.6 Invasion assay
Wild-type, mho1∆ and MHO1 overexpressing Σ1278b strains were streaked out on
YPD (yeast extract/peptone/dextrose) and YPGal (yeast extract/peptone/galactose)
plates and were grown for 4-5 days at 30C. The plates were equally washed under a
constant water stream to wash of non invasive strains.
3.5.7 SL Screen
In the yeast strain haploid matingtype-selectable Y5563 (MATα; lys1∆; his3∆1; leu2∆0;
ura3∆0; met15∆0; can1::Mfapr-His3 ) strain we deleted MHO1 with the natMX dele-
tion cassette and thus making it resistant to nourseothricin. The Y5563 mho1::natMX
strain was then subsequently mated with each of the 4800 viable haploid deletion strains
that were purchased from invitrogenTM. The mating was performed on agar plates in a
96-well format using standard methods on a singer pinning robot (RoToR HDA pinning
robots from singer; www.singerinstruments.com).
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3.8 Figure legends
3.8.1 Figure 1: Phylogenetic tree and sequence alignment of Memo
homologues in all kingdoms of life.
(A) The evolutionary distances between Memo protein sequences in the listed species
are shown, using the human Memo as the query sequence. The % identity and %
similarity, respectively, are indicated in brackets. (B) The protein sequence of Memo
homologues in the species shown in panel A are presented. The red letters indicate the
conserved amino acids in the putative active site [3].
3.8.2 Figure 2: Cytoskeleton analysis of wild-type and memo∆ strains
of S. cerevisiae.
(A) To stain the tubulin cytoskeleton, a GFP-tagged TUB1 expression vector, under
its endogenous promoter was introduced into wild type and memo∆ cells. The arrows
indicate (1) nuclear microtubules, (2) astral microtubules, and (3) the spindle pole
body. (B) Phalloidin-OregonGreen was used to stain wild type and memo∆ cells. Two
actin structures are stained: (1) cortical actin patches and (2) actin cables. There are
no obvious differences in the microtubule structures or the actin cytoskeleton between
wild-type and memo∆ cells.
3.8.3 Figure 3: Examination of filamentous growth in wild type and
memo∆ cells.
(A) Actin was visualized in wild type and memo∆ Ashbya gossypii by staining with
Phalloidin-OregonGreen. The stained actin structures are: (1) cortical actin patches,
(2) actin patches at the tip, (3) actin rings at sites of septation, and (4) actin cables.
There are no observable differences in the actin cytoskeleton between wild type and
memo∆ strains. (B) A polarized growth assay was performed in Ashbya gossypii.
Spores from the wild type and the memo∆ strain were spotted in the middle of an agar
plate with full medium and radial growth was measured during 7 days. The picture was
taken at the end of the experiment. (C) Shmoo formantion of wild type and memo∆
cells was visualized on YPD agar-coated microscopy slides, following stimulation of
MATa cells for 4 hrs with α-factor.
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3.8.4 Figure 4: Cellular localization of Memo in yeast and mammalian
cells.
(A) Endogenous Mho1 was tagged C-terminally with GFP by homologous recombina-
tion in order to visualize Mho1. Yeast cells were grown 48 hrs to stationary phase
in YPD and GFP was visualised by fluorescence microscopy. Mho1-GFP is present
in the cytoplasm (c), the nucleus (n), and is excluded from the vacuole (v). (B) The
human Memo-GFP was expressed in yeast cells and visualized. Memo is present in
the cytoplasm, the nucleus and excluded from the vacuole. (C) Endogenous Memo was
visualized in mouse embryonic fibroblasts (MEFs) using a specific Memo antiserum [1].
Memo is present in the cytoplasm (2), the nucleus (1) and is excluded from the nucleoli
(3). (D) The same antibody was used for Memo staining in SKBR3 breast tumor cells.
(left panel) Memo is found in the cytoplasm and the nucleus in cells grown in DMEM
containing 10% FCS. (right panel) following treatment of cultures for 20 min with 10
nM HRG, Memo is recruited to the membrane. Quantification of nuclear signal inten-
sity versus signal intensity outside the nucleus showed that the levels of nuclear Memo
are approximately the same before and after the treatment.
3.8.5 Figure 5: Identification of a functional nuclear export sequence
in Memo homologues.
(A) Using the NetNES 1.1 nuclear export sequence prediction software from CBS (Cen-
ter for Biological Sequence analysis) a predicted NES, which is conserved various species
was identified and highlighted in red. LxxxLxxLxL (L= Leucine or hydrophobic amino
acid and X= any amino acid). (B ) The NES of Memo is located between β-sheet 2 and
α-helixC on a long loop on the surface of the protein (indicated by the red line). (C)
IF for endogenous Memo in human SKBR3 breast tumor cells. The cells were treated
with: 10% FCS -/+ Leptomycin B (panels A vs C), 10% FCS + HRG -/+ Leptomycin
B (panels B vs D). Leptomycin B treatment was overnight.
3.8.6 Figure 6: MEMO is synthetic lethal with PLC1.
(A) Amemo∆ a-strain (memo::kanMX ) was mated to a plc1∆ α-strain (plc1::natMX ).
The resulting diploid strain was sporulated, the spores were grown on YPD plates
and growing colonies were streaked out on YPD plates with G418 or ClonNat to test
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for memo∆ and plc1∆, respectively. The location of the memo∆plc1∆ spores, where
there was no growth, are indicated by white circle. plc1∆ colonies grow slower and are
smaller. (B) The PLC1 gene including its endogenous promoter and terminator were
cloned into a CEN/ARS plasmid with the URA3MX selection marker (pRS416 PLC1).
(C) By sporulating a diploid heterozygous memo∆/MHO1 ; plc1∆/PLC1 deletion
strain harbouring the PLC1 expressing CEN/ARS plasmid, the three haploid deletion
strains: memo∆, plc1∆, and memo∆plc1∆ were created. Thes three and the wild-type
strain were grown on SD-URA plates to select for the pRS416 PLC1 plasmid. When
streaked on a 5-FOA plate, which selects for loss of the plasmid, all but the double-
deleted cells grow, showing that once Plc1 expression is lost, cells stop growing. (D)
A mho1::hMEMO natMX strain was mated with a plc1::kanMX strain. The resulting
diploid strain was sporulated and the spores were dissected on YPD. The upper portion
of the figure shows the growing colonies, the lower portion shows the phenotype. The
red triangles indicate the mho1::hMEMO natMX plc1::kanMX strain proving that the
human protein can complement for Mho1 in this assay.
3.8.7 Figure 7: Overexpression of Mho1 abolishes invasive growth in
the haploid Σ1278B strain.
(A) Mho1 was overexpressed in the invasive yeast strain Σ1278B by integrating the
pRS416 pGAL 6HIS-MHO1 and the BYintURA pGAL MHO1 plasmids. The memo∆
strains were made by replacing the endogenous gene with kanMX or URA3MX. (B)
Overexpression of 6His-Mho1 is shown by western blotting using a His-tag specific an-
tiserum. Mcm2 levels were used as a loading control. The lysates were: 1) Σ1278B
wt grown on YPD, 2) Σ1278B wt grown on YPGal, 3) Σ1278B 6His-Mho1 OE grown
on YPD, and 4) Σ1278B 6His-Mho1 OE grown on YPGal. (C) To test for invasive
growth potential in strains lacking Mho1 or overexpressing the protein, the indicated
strains were streaked out on YPD or YPGal (overexpressing conditions) agar plates.
As controls, the wt Σ1278B or Σ1278B harbouring the empty pRS416 pGAL and BY-
intURA pGAL plasmid were used. After four days, the plates were washed under the
water tap. Only cells overexpressing Mho1 on the YPGal plates were washed off the
plates, showing that overexpression blocks haploid invasive growth.
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3.9 Supplemental material
3.9.1 Figure S1: Spotting assay of wild-type and mho1∆ strains on
various compounds
A wild-type and a mho1∆ strain were serial diluted and spotted on YPD plates (A)
or SD complete plates (B), containing 800µM CoCl2, 100µM benomyl, or 100µM ra-
pamycin (A and B) and 800µM NaCl, or HU 100µM (B). No differences in growth
between the mho1∆ and the wild-type strains were observed.
3.9.2 Figure S2: MHO1 expression analysis
A summary of the published MHO1 microarray data is presented. Conditions that
increase or decrease MHO1 expression are indicated in red or green, respectively. The
data was taken from http://transcriptome.ens.fr/ymgv/. MHO1 is upregulated upon
Msn2 overexpression leading to the hypothesis that MHO1 is a a stress response gene.
3.9.3 Figure S3: Comparison of published MHO1 and PLC1 microar-
ray data
Microarray data from Gasch et al., 2000 [19] analyzing the gene expression of yeast cells
in response to environmental stress was used to compare MHO1 and PLC1 regulation.
3.9.4 Figure S4: MHO1 promoter analysis
(A) An analysis of the MHO1 promoter region (-1bp to -500bp from the START codon)
revealed that there are two potential binding sites for Msn2/Msn4 (shown in green) and
a potential UASino (inositol-sensitive upstream activating sequence) binding site. The
latter is often present in promoters of genes encoding phospholipid, fatty acid, and sterol
biosynthetic enzymes. (B) Using the YEASTRACT (Yeast Search for Transcriptional
Regulators And Consensus Tracking; database (http://www.yeastract.com/index.php),
we identified a list of transcription factors that directly or indirectly regulate MHO1
transcription
3.9.5 Figure S5: IP3 signaling pathway
IP3 and DAG are produced by the cleavage of PIP2 by Plc1. IP3 is released from the
membrane and is the precursor of all other inositol phosphates (IPs). The four inositol
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polyphosphate kinases (Ipk2/Arg82, Ipk1, Ksc1, and VIP1) further process IP3 and
constitute a nuclear signaling pathway. The major functions affected by the different
IPs and the primary references are shown in this figure.
IP4 ⇒ Gene expression and Chromatin remodeling: [36,37,38,39,40,41]
IP5 ⇒ Telomere length and DNA repair: [42,43,44,45]
IP6⇒mRNA Export, Non Homologous End Joining, RNA editing: [21,46,47,48,49]
3.9.6 Table S1
Genes involved in the cAMP/PKA/PLC pathway, which were tested with the mho1∆
strain; none were SL with mho1∆.
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3.10 Tables
Name Genotype Reference
BY4741 MATa; his3∆1; leu2∆0; met15∆0; ura3∆0 [5]
BY4742 MATα; his3∆1; leu2∆0; lys2∆0; ura3∆0 [5]
BY4743 MATa/MAT? his3∆0/his3∆0; leu2∆0/leu2∆0;
met15∆0/MET15; LYS2/lys2∆0; ura3∆0/ura3∆0
[5]
DHY194 MAT?; ura3-52∆1::GFP-TUB1-URA3(pAFS125);
trp1∆63; leu2∆1; his3∆200
[31]
Y5563 MATα; lyp1∆; his3∆1; leu2∆0; ura3∆0; met15∆0;
can1::Mfapr-His3
[32]
Σ1278 MATa; ura3∆0 [18]
ISY42 MATα; his3∆;1 leu2∆0; lys2∆0; ura3∆0; mho1∆::natMX this study
ISY34 MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; plc1∆::kanMX this study
ISY5 MATα; ura3-52∆1::GFP-TUB1-URA3(pAFS125);
trp1∆63; leu2∆1; his3∆200 mho1∆1::klTRP1
this study
ISY120 MATa; ura3∆0; mho1∆::natMX this study
ISY229 MATa; ura3∆0; mho1∆::URA3 this study
ISY231 MATa; ura3∆0::BYintURA PGAL ADHterm URA3 this study
ISY129 MATa; ura3∆0::BYintURA PGAL 6His-
MHO1 ADHterm URA3
this study
ISY38 MATα; lyp1∆; his3∆1; leu2∆0; ura3∆0; met15∆0;
can1∆::Mfapr-His3; mho1∆::natMX
this study
ISY120 MATa; ura3∆0::mho1∆::natMX this study
ISY229 MATa; ura3∆0::mho1∆::URA3 this study
ISY211 MATa; ura3∆0; pRS416 this study
ISY203 MATa; ura3∆0; pRS416 pGAL 6HIS-MHO1 this study
ISY203 MATa; ura3∆0; pRS416-6HIS-humanMEMO this study
Table 3.1: S. cerevisiae strains used in this study
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Name Genotype Reference
WT leu2∆; thr4∆ (∆l∆t) [33]
AGR321W∆ leu2∆; thr4∆; agr321w∆::GEN3 this study
Table 3.2: A. gossypii strains used in this study
Plasmid Reference
pFA6 kanMX6 [24]
pFA GFP(s65t) kanMX6 [13]
pAG25 [25]
pRS416 [34]
pGEN3 [11]
pSO142 [35]
pRS416 pPLC1 PLC1 PLC1term this study
pRS416 pGAL ADHterm this study
pRS416 pGAL 6HIS-MHO1 ADHterm this study
BYintURA pGAL ADHterm personal communication
BYintURA pGAL eGFP-hMEMO ADHterm this study
BYintURA pGAL MHO1 ADHterm this study
pAG25 hMEMO this study
pAG25 MYC-hMEMO this study
Table 3.3: Plasmids strains used in this study
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3.11 Figures
 
 
 
 
 
 
 
archea 
bacteria 
fungi 
mammals 
nematoda 
amphibia 
osteichthyes 
amoebozoa 
P. calidifontis (24% / 41%)
M. jannaschii (25% / 41%)
Hydrogenobaculum sp. (24% / 43%)
M. methanica (29% / 46%)
S. pombe (38% / 55%)
S. cerevisiae (37% / 55%)
D. discoideum (45% / 62%)
C. elegans (44% / 57%)
X. laevis (90% / 98%)
D. rerio (88% / 95%)
H. sapiens
M. musculus (99% / 100%)
B. taurus (92% / 94%)
R. norvegicus (99% / 100%)
A
B
H. sapienas        IIAPHAGYTYCGSCAAHAYKQVDPS----ITRRIFILGPSHHVPLS / LFVVSSDFCHWGQ / TICGRHPI
M. musculus        IIAPHAGYTYCGSCAAHAYKQVDPS----VTRRIFILGPSHHVPLS / LFVVSSDFCHWGQ / TICGRHPI
R. norvegicus      IIAPHAGYTYCGSCAAHAYKQVDPS----ITRRIFILGPSHHVPLS / LFVVSSDFCHWGQ / TICGRHPI
B. taurus          IIAPHAGYTYCGSCAAHAYKQVDPS----ITRRIFILGPSHHVPLS / LFVVSSDFCHWGQ / TICGRHPI
D. rerio           IIAPHAGYTYCGACAAHAYKQVDPS----ITRRVFILGPSHHVPLS / LFIISPDFCHWGQ / TICGRHPI
C. elegans         LISPHAGYSYCGETAAYAFKQVVSS----AVERVFILGPSHVVALN / LFVISSDFCHWGE / TICGRNPI
D. discoideum      IIAPHAGYSYSGRAAAYAYINLIPE----NYKRVFILGPSHHVYMK / FFVISSDFCHWGE / TICGRCPI
S. pombe           VISPHAGYMYSGKVASQGFQQLDFS----KIQRVFVFGPSHHIFTR / SFVISSDFCHWGR / TICGRYPI
S. cerevisiae      IICPHAGYRYCGPTMAYSYASLDLN---RNVKRIFILGPSHHIYFK / LFIVSSDFCHWGR / TICGEKPI
P. calidifontis    GVVPHAGYMYSGPVAAWLYSALAGY---GAPTTFVIIGPNHYGIGA / YLLASSDFNHYEP / SICGIGPI
M. jannaschii      LLCPHAGYVYSGPIQAHSYYELSKRVDALEETTVVILGPNHTGLGS / VVIASSDLTHYEP / SMCGYGPV
M. methanica       IIVPHAGYIYSGPIAASAYARLKPV--RDSVSRVVLIGPSHRVAFQ / LIVISSDLSHYHD / AACGRVPV
D. turgidum        CVVPHAGYIYSGKVAGLIYSIME------VPEVAIIIGPNHNGLGY / VIIASSDFSHYEP / SICGVGPI
Hydrogenobaculum   VIVPHAGYIYSGHTACSVYKRLKP----K--KNIIMMGPNHTGQGP / LILVSSDMSHYIS / TMCGFIPA
                    : ***** *.*      :  :            .::**.*      /  .: *.*: *:   / : **  *  
49 81 244192189
Figure 3.1: Phylogenetic tree and sequence alignment of Memo homologues in
all kingdoms of life. -
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Figure 3.2: Cytoskeleton analysis of wild-type and memo∆ strains of S. cere-
visiae. -
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Figure 3.3: Examination of filamentous growth in wild type and memo∆ cells.
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M. musculus        LSSVDIYRTPLYDLRIDQKIYGE
R. norvegicus      LSSVDIYRTPLYDLRIDQKIYGE
H. sapiens         LSSVDIYRTPLYDLRIDQKIYGE
B. taurus          LSSVDIYRTPLYDLRIDQKIYGE
X. laevis          LSTVDIYRTPLYDLHVDQKVYGE
D. rerio           LSPAEVYRTPLYDLRIDQKVYAD
C. elegans         ITTCSKYRTPLGDLIVDHKINEE
D. discoideum      LTKLDTWETPIGNLKVDKDTTNK
S. pombe           VSRASICSTPLGDLKVDEDLCQK
S. cerevisiae      VSAFSELETPLGNLKVDTDLCKT
P. calidifontis    IMKSGAWETPFGRVEIDEELASL
M. jannaschii      VMD-GIWRTPLGDVKCDEEFVEE
A B
C
MemoMemo DapiDapi
B
D
A
C
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over night
60 ng/ml 
Leptomycin B 
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Figure 3.5: Identification of a functional nuclear export sequence in Memo
homologues. -
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Figure 3.7: Overexpression of Mho1 abolishes invasive growth in the haploid
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Figure 3.9: MHO1 expression analysis -
Response to stationary 
phase, 1-13 days (25°C)
Upregulated > 12-fold within  12 hrs and 
remains elevated
Upregulated slowly; reaches a maximum of 
~ 2-fold after 2 days  
Response to stationary 
phase, 5 days (30°C)
Rapidly induced; 16-fold within 10 hrs  Upregulated slowly; reaches a maximum of 
~ 2-fold after 2 days  
Response to nitrogen deple-
tion over 3 days
Heat shock (17-33°C) to 37°C 
Rapidly upregulated 5-fold Slowly upregulated 1.5 fold
Unchanged
UnchangedRapidly upregulated > 5-fold
Downregulation of > 2 foldCold shock 37° to 25°C
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Arraydata from Gasch et al., Mol Biol Cell, 2000
Regulation of MHO1 and PLC1 expression levels in response to environmental stress conditions:
Figure 3.10: Comparison of published MHO1 and PLC1 microarray data -
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A
MHO1
ATG
Ino2
Ino4Msn4
Msn2
-135-172
-206 GGGGA CATGTG
GGGGA
Msn4
Msn2
A
B
GENE Function
Aro80 Zinc finger transcriptional activator of the Zn2Cys6 family; activates transcription of aromatic amino acid catabolic genes in the presence of aromatic amino acids
Gcn4
Basic leucine zipper (bZIP) transcriptional activator of amino acid biosynthetic genes in response to amino acid starvation; expression is tightly regulated at both the 
transcriptional and translational levels
Gcr2 Transcriptional activator of genes involved in glycolysis; interacts and functions with the DNA-binding protein Gcr1p
Hot1
Transcription factor required for the transient induction of glycerol biosynthetic genes GPD1 and GPP2 in response to high osmolarity; targets Hog1p to osmostress 
responsive promoters; has similarity to Msn1p and Gcr1p
Hsf1
Trimeric heat shock transcription factor, activates multiple genes in response to stresses that include hyperthermia; recognizes variable heat shock elements (HSEs) 
consisting of inverted NGAAN repeats; posttranslationally regulated
Ino2
Component of the heteromeric Ino2p/Ino4p basic helix-loop-helix transcription activator that binds inositol/choline-responsive elements (ICREs), required for 
derepression of phospholipid biosynthetic genes in response to inositol depletion
Ino4
Transcription factor required for derepression of inositol-choline-regulated genes involved in phospholipid synthesis; forms a complex, with Ino2p, that binds the 
inositol-choline-responsive element through a basic helix-loop-helix domain
Met4
Leucine-zipper transcriptional activator, responsible for the regulation of the sulfur amino acid pathway, requires different combinations of the auxiliary factors Cbf1p, 
Met28p, Met31p and Met32p
Msn2
Transcriptional activator related to Msn4p; activated in stress conditions, which results in translocation from the cytoplasm to the nucleus; binds DNA at stress response 
elements of responsive genes, inducing gene expression
Msn4
Transcriptional activator related to Msn2p; activated in stress conditions, which results in translocation from the cytoplasm to the nucleus; binds DNA at stress response 
elements of responsive genes, inducing gene expression
Opi1
Transcriptional regulator of a variety of genes; phosphorylation by protein kinase A stimulates Opi1p function in negative regulation of phospholipid biosynthetic genes; 
involved in telomere maintenance
Stp1
Transcription factor, undergoes proteolytic processing by SPS (Ssy1p-Ptr3p-Ssy5p)-sensor component Ssy5p in response to extracellular amino acids; activates 
transcription of amino acid permease genes and may have a role in tRNA processing
Stp2
Transcription factor, activated by proteolytic processing in response to signals from the SPS sensor system for external amino acids; activates transcription of amino acid 
permease genes
Yap5 Basic leucine zipper (bZIP) transcription factor
Yap6
Putative basic leucine zipper (bZIP) transcription factor; physically interacts with the Tup1-Cyc8 complex and recruits Tup1p to its targets; overexpression increases 
sodium and lithium tolerance; computational analysis suggests a role in regulation of expression of genes involved in carbohydrate metabolism
Figure 3.11: MHO1 promoter analysis -
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Figure 3.12: IP3 signaling pathway -
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3.13 Supplemental Table S1
Gene Function (from www.yeastgenome.org
BUB11 Protein kinase involved in the cell cycle checkpoint into anaphase; forms
complex with Mad1p and Bub3p crucial to preventing cell cycle progres-
sion into anaphase in the presence of spindle damage
BUB31 Kinetochore checkpoint WD40 repeat protein that localizes to kineto-
chores during prophase and metaphase, delays anaphase in the presence
of unattached kinetochores
CBF21 Essential kinetochore protein, component of the CBF3 multisubunit
complex that binds to the CDEIII region of the centromere; Cbf2p also
binds to the CDEII region possibly forming a different multimeric com-
plex, ubiquitinated in vivo
MAD21 Component of the spindle-assembly checkpoint complex; delays the on-
set of anaphase in cells with defects in mitotic spindle assembly; reg-
ulates APC/C activity during prometaphase and metaphase of meiosis
I
ARG82/IPK22 Inositol polyphosphate multikinase (IPMK), sequentially phosphory-
lates Ins(1,4,5)P3 to form Ins(1,3,4,5,6)P5; also has diphosphoinositol
polyphosphate synthase activity; regulates arginine-, phosphate-, and
nitrogen-responsive genes
IPK12 Inositol 1,3,4,5,6-pentakisphosphate 2-kinase, nuclear protein required
for synthesis of 1,2,3,4,5,6-hexakisphosphate (phytate), which is integral
to cell function
KCS12 Inositol hexakisphosphate (IP6) and inositol heptakisphosphate (IP7)
kinase; generation of high energy inositol pyrophosphates by Kcs1p is
required for many processes such as vacuolar biogenesis, stress response
and telomere maintenance
VIP12 Inositol hexakisphosphate (IP6) and inositol heptakisphosphate (IP7)
kinase; IP7 production is important for phosphate signaling; involved in
cortical actin cytoskeleton function, and invasive pseudohyphal growth
RAS13 GTPase involved in G-protein signaling in the adenylate cyclase acti-
vating pathway, plays a role in cell proliferation; localized to the plasma
membrane; homolog of mammalian RAS proto-oncogenes
RAS23 GTP-binding protein that regulates the nitrogen starvation response,
sporulation, and filamentous growth; farnesylation and palmitoylation
required for activity and localization to plasma membrane; homolog of
mammalian Ras proto-oncogenes
IRA23 GTPase-activating protein that negatively regulates RAS by converting
it from the GTP- to the GDP-bound inactive form, required for reducing
cAMP levels under nutrient limiting conditions, has similarity to Ira1p
and human neurofibromin
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GPA23 Nucleotide binding alpha subunit of the heterotrimeric G protein that
interacts with the receptor Gpr1p, has signaling role in response to nu-
trients; green fluorescent protein (GFP)-fusion protein localizes to the
cell periphery
Table 3.4: Genes that were tested as SL with memo∆ based on their known
roles in the cAMP/PKA/PLC pathways - 1: Published genes having a SL phenotype
with plc1∆. 2: The four inositol polyphosphate kinases downstream of Plc1 which further
process IP3 to IP4, IP5, and IP6.
3: Genes involved the cAMP/PKA pathway signalling.
4Results
4.1 TAPtagging Mho1
To answer the question if Mho1 has putative binding partners in yeast we performed
a TAP tag experiment. The endogenous protein was tagged at the C-terminus with a
TAP (Tandem Affinity Purification) tag (90). The TAP tag consists of two IgG binding
domains of Staphylococcus aureus protein A (ProtA) and a calmodulin binding peptide
(CBP) separated by a TEV (Tobacco Etch Virus) protease cleavage site. Because the
endogenous protein is tagged by insertion of a fusion cassette at the 3’-end of the gene
on the chromosome, the expression is still controlled under the endogenous promoter
and by this kept close to natural level. The C-terminal TAP-tag fusion cassette consists
of the CBD sequence, the TEV cleavage site and the ProtA sequence so that the ProtA
module is located at the extreme C-terminus of the fusion protein. On the same fusion
cassette there is also a HIS3MX6 marker for selection integration of the cassette (Figure
4.1 (37)).
The significant advantage of this technique is the two separate purification steps
of the fusion protein to reduce false positive hits, e.g. non specific protein binding
to the tag or to the protein complex to be pulled down. First ProtA binds tightly
to an IgG matrix, then the TEV protease cuts the tag at the TEV cleavage site and
by this eluting the proteins under native conditions (Figure 4.2). The eluate of this
first affinity purification step is then incubated with calmodulin-coated beads in the
presence of calcium. After washing, which removes contaminants and remnants TEV
protease, the bound material is released under mild conditions with EGTA (Figure
83
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Figure 4.1: Insertion of C-terminal fusion cassette - The TAPtag fusion cassette
encodes for the TAPtag (A CBP (calmodulin binding domain. followed by TEV-C (TEV
cleavage site) and two IgG binding domains from Protein A) and the HIS3MX6 selection
marker. At the 5’ and 3’ end the fusion cassette shares homology to the sites of integration
on the chromosome. The cassette gets integrated in frame at the 3’ end of the gene and
by this deleting the STOP codon. The TAPtagged gene encodes for the protein with a
TAP tag at its C-terminus. As the gene is still controlled under its endogenous promoter,
protein levels are close to natural levels.
4.2). The final elutant can either be used for silver or coomassie gel analysis (Figure
4.2) or can directly be used for Mass spectrometry analysis (Figure 4.2).
For our analysis we used a Mho1-TAP tagged strain and the wild-type BY4741
strain. Both strains were grown to OD600 2 or 12, harvested, lysed and affinity purified
as described in the method section. The final elutant was split into two fractions and
TCA precipitated. One fraction was used for loading on a SDS-PAGE gradient gel
from sigma and subsequent staining with silver ions (see Figure 4.3).
The second fraction was send to the in-house protein analysis facility for mass-
spectrometry analysis. The samples were Trypsin digested and analysed using a LTQ
Orbitrap Velos (Thermo Scientific) equipped with Agilent 1100/1200 Nanoflow LC
System for nano-spray MS (Agilent Technologies). The Data could be analyzed using
the Mascot (Matrix Science) software.
Mass spectrometry analysis identified two proteins pulled down only with Mho1
but not in the wild-type control (The control was a wild-type strain not expressing a
TAP-tagged protein but grown, lysed and purified in parallel to the MHo1-TAP strain).
• Ubp3: Ubiquitin-specific protease involved in transport and osmotic response
4.1. TAPTAGGING MHO1 85
Figure 4.2: TAPtagging of Mho1 - The fusion protein was expressed from yeast cells
having TAP tagged the endogenous MHO1 gene. Whole cell lysate (WCL) was run over a
column with IgG-Sepharose beads binding the Protein A tag. After washing the Mho-TAP
fusion protein and associated proteins were eluted by cleavage with TEV (Tobacco Etch
Virus) protease. The elutant was runover a second column with calmodulin beads. In the
presence of Ca2+ the calmodulin binding domain from the TAP tag can bind. The second
elution is done by chelating Ca2+ with EDTA and so releasing the Mho1 protein complex
from the beads. The elutant can be used for SDS-PAGE and silver staining or for mass
spectrometry analysis.
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Figure 4.3: Sliver gel Mho1-TAP and BY4741 strains - The figure shows the
final elutant of a TAP tag purification using a Mho1-TAP strain and the wild-type strain
BY4741
• Hsp60: Tetradecameric mitochondrial chaperonin required for ATP-dependent
folding of precursor polypeptides and complex assembly
• Mho1: TAP tagged protein in this experiment, was only found in the Mho1-TAP
sample (positive control)
Next we wanted to find out how stringent the interaction between Mho1 and the
two found protein is. We ran again a TAP tag experiment, but increased the NaCl
concentration during the purification steps from 150 mM to 300 mM and 500 mM.
With 300 mM NaCl only Hsp60 could be pulled down with Mho1. A further increase
to 500 mM NaCl abolished all interactions between Mho1 binding partners. Only Mho1
(the TAP tagged protein) was identified by mass. spec.
In an other experiments we TAP tagged potential interaction partners of Mho1
and analyzed the final elutant after the two purification steps specifically for Mho1
fragments. We have chosen to TAP tag the following proteins:
• Ubp3: was pulled down with Mho1
• Arp1: Actin-related protein of the dynactin complex; required for spindle orien-
tation and nuclear migration. In the yeast-2-hybrid screen from (49) Mho1 was
found to interact with Arp1
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• Cof1: Cofilin, promotes actin filament depolarization in a pH-dependent manner;
binds both actin monomers and filaments and severs filaments. In A yeast 2
hybrid screen performed by Maria Meira using a blood cDNA library Cof1 was
one of the identified binding partners of Memo. Meira et. al, 2009 showed that
in mammalian cells Memo interacts with cofilin after HRG stimulation (70)
• Hsp60 could not be TAP tagged. It seams that the essential protein Hsp60 is not
functioning or is miss folded after TAP tagging.
Non of the TAP tagged protein could pull down Mho1. The TAP tag experiment
itself worked fine. We could identify several already published interactions in our assay.
With Cof1 we could pull down:
• Act1: Actin, structural protein involved in cell polarization, endocytosis, and
other cytoskeletal functions
• Srv2: CAP (cyclase-associated protein) subunit of adenylyl cyclase complex
As further control to assure ourselves that the TAP-tagging experiment was success-
ful we compared our hit with with already published data sets. With Arp1 we could
pull down Jnm1 (Component of the yeast dynactin complex, consisting of Nip100p,
Jnm1p, and Arp1p; required for proper nuclear migration and spindle partitioning dur-
ing mitotic anaphase). But interestingly we could also pull down many members of
the T-complex protein 1 subunits. Those are molecular chaperone; which assists the
folding of proteins upon ATP hydrolysis. They are known to play a role, in vitro, in
the folding of actin and tubulin. In yeast the T-complex protein 1 subunits may play
a role in mitotic spindle formation.
With this experiment we showed that Mho1 could only pull down Hsp60. The
interaction between Mho1 and Hsp60 is stringent, even the increase of the NaCl con-
centration to 300 mM could not interrupt this interaction. Whether this interaction is
real, meaning the two protein interact in the cell, or if this is just a post lysis interaction
we could not answer. However, Hsp60 is a molecular chaperone mainly localizing to
the mitochondrial matrix and we never could see Mho1 localize to the mitochondria.
We think that this observed interaction is likely to be an experimental artrefact and
not a true interaction occurring in living cells.
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4.2 dSLAM (SL Screen)
One of the reasons why we choose S. cerevisiae as model system to elucidating Mho1
function is the possibility to do large scale genetics. Synthetic lethal interaction is a
major tool to get insight into molecular pathway. If a strain harboring two deletion
which alone are viable in combination show a slow growing phenotype (synthetic sick)
or do not grow at all (synthetic lethal) shows a high possibility that the two encoded
genes function in two distinct, but complementary pathways (Figure 1.9). We used the
novel dSLAM (heterozygote diploid-based synthetic lethality analysis with microarrays)
technique (71, 79, 80) to screen for synthetic interaction partners of MHO1. The
dSLAM screen has two main advantages compared to the ”conventional” described in
the chapter ”3.5.7 SL Screen”. First, we could start with a diploid heterozygous deletion
collection instead of a haploid deletion collection. This means also the essential deletions
are included in the screen giving the possibility to find synthetic rescue interactions (the
deletion of an essential gene is rescued by the deletion of a second gene). And second,
al the deletion strains are molecularly bar-coded, they all have two unique 20 base
pair tags flanked by universal priming sites. This feature is crucial as it means all the
deletion strains can be pooled and handled in liquid. The system is comparable to the
one we all know from the stores when we go grocery shopping. The product of interest
is tagged with a bar code. At the cash register the bar code gets scanned and provides
information about the product, the price, but also how many pieces are left in the shelf
(Figure 4.4).
Figure 4.4: BAR code and scanner -
The genetic bar code of the deletion strains consists of 20 bp. Instead of a scanner,
the bar code can get amplified by PCR, hybridization on a chip and read by a microar-
ray scanned. This gives us information which mutants are present before and after a
”change”, e.g. before and after introduction of the query deletion (Figure 4.5).
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Figure 4.5: Scanning of molecular BAR codes -
The dSLAM experiment was performed as described in (79) (A flowchart of the
dSLAM experiment is shownn in Figure 4.6). We used the SalI EcoRI cut plas-
mid pSO142-4 for exchanging the kanMX marker of the memo∆ strain with the
pTEF pURA3-URA3 tTEF cassette.
We run the whole dSLAM experiment twice using the URA3 selection marker for
deleting Memo in the pool of diploid heterozygous deletion strains. The obtained results
after chip analysis and data processing are shown in figure 4.7.
For both experiments we obtained potential genes being SL with MHO1. But when
we plotted the two experiments against each other we could not see any correlation.
Genes which showed up in the first experiment to be SL with Mho1 did not show up in
the second or vice versa. The known SL interaction partner of MHO1, PLC1 did not
show up in any of the dSLAM experiments. This may be because the signal from the
plc1∆ strain was not amplified enough and was lower than the set threshold, meaning
the single and the double deleted strain grew too slow.
To further analyze the dSLAM method we repeated the experiment again with a
different selection marker, using the kanMX marker (106) from the plasmid pAG25
(40) to construct the query deletion cassette. We performed the dSLAM experiment
six times in parallel. Data analysis and cross comparison of the single experiment
showed again no correlation between the six experiments. The signal from the chip
analysis was very low for most strains which is an indication for poor growth in the
final selection medium.
4.3 Microarray (Does Mho1 control transcription?)
As Memo/Mho1 localizes predominantely to the nucleus in mammalian and yeast cells
we wanted to answer the question if Mho1 in yeast affects the transcription of genes
and if so if this is a direct or indirect effect. We extracted RNA from wild-type and
mho1∆ strains. Both strains were harvested either during growth in mid log phase (low
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Figure 4.6: Flowchart of a dSLAM screen - Figure from (79)
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A
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Figure 4.7: dSLAM results - Shown are the figures made with spotfire presenting the
results of the two dSLAM experiments. Each deletion strain is represented by a square. All
blue squares are non essential gene deletions whereas the red ones represent the essential
gene deletion. The grey squares are labeled with ”empty” and are mostly dubious ORFs
or are not annotated. On the y-axis the genes are aligned according their names starting
with A. On the x-axis the ”relative survival rate” is shown (if the single deletion strain
grows the same as the double deleted strain this value is 0. If the double deleted strain is
synthetic lethal the value is highly negative, whereas if the double deleted strains grown
much better it is shown by a positive value. So all the blue squares below the -5 mark on
the x-axis show a synthetic sick or lethal phenotype with mho1∆.
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expression of Mho1) or after 48h in stationary phase (strong upregulation of Mho1).
Evaluation of microarrays was done as described in Materials and Methods. From
duplicate analysis of wild-type or deletion strains grown to mid-log phase or stationary
phase, we selected those probe sets with a Log2 average contrast signal of at least 5,
an adjusted p-value < 0.05 and an absolute Log2 fold change of > 1 (2-fold in linear
space).
In table 4.1 all the genes are shown that show at least a 2 fold change in mho1∆
strains compared to wild-type strains when cells were harvested during growth in mid-
log phase. Under this growth condition Mho1 is expressed at very low levels.
Systematic name Common name Log2 FC Description
snR49 SNR49 1.21 H/ACA box small nucleolar RNA
(snoRNA)
YPR202W 1.21 Putative protein of unknown func-
tion with similarity to telomere-
encoded helicases
tL(UAA)Q tL(UAA)Q -2.31102 Mitochondrial tRNA-Leu, required
for mitochondrial translation and
indirectly for maintenance of the mi-
tochondrial genome
YDL246C SOR2 -1.02082 Protein of unknown function; pro-
tein sequence is 99% identical to the
Sor1p sorbitol dehydrogenase
YER188W -1.06896 Dubious open reading frame un-
likely to encode a protein
YIR040C -1.44395 Dubious open reading frame un-
likely to encode a protein
YLR157W-D -1.836005 Putative protein of unknown func-
tion; identified by gene-trapping,
microarray-based expression anal-
ysis, and genome-wide homology
searching
Table 4.1: Genes changed in mho1∆ strain compared to wild-type when grown
to mid-log phase - In this table all the genes having at least a 2 times fold change in
mho1∆ cells compared to wild-type cells when the cells are grown to mid-log phase.
4.4. COULDMEMO/MHO1 BE AN ENZYME? - ENZYMATIC ACTIVITY ASSAYS93
In table the table 4.2 all the genes are shown that show at least a 2 fold change in
mho1∆ strains compared to wild-type strains when cells were harvested after 48 hours
in stationary phase. Under this growth conditions Mho1 is rapidly upregulated up to
16 times. .
Systematic name Common name Log2 FC Description
tQ(UUG)E2 -1.99 tRNA-Gln; thiolation of uridine at
wobble position
YBR174C -1.14 Dubious open reading frame un-
likely to encode a protein
YEL020C-B -3.24 Dubious open reading frame un-
likely to encode a protein
YER146W LSM5 -1.13 Lsm (Like Sm) protein; part of het-
eroheptameric complexes (Lsm2p-
7p and either Lsm1p or 8p): cyto-
plasmic Lsm1p complex involved in
mRNA decay
YGL069C SRF3 -1.35 Dubious open reading frame, un-
likely to encode a protein
Table 4.2: Genes changed in mho1∆ strain compared to wild-type when grown
to stationary phase - In this table all the genes having at least a 2 times fold change
in mho1∆ cells compared to wild-type cells when the cells are grown for 48 hours into
stationary phase.
Even though Mho1 gets strongly upregulated during stationary phase and local-
izytion of the protein is mainly nuclear our analysis suggest that Mho1 has little or
no influence on the transcription of other genes. It is highly unlikely that Mho1 is a
regulator of transcription or even a transcription factor.
4.4 Could Memo/Mho1 be an enzyme? - Enzymatic ac-
tivity assays
4.4.1 Is Memo a Non-heme Dioxygenase?
The structure from Memo was solved by Qiu et. al (89) and was shown to by structurally
homologue to LigB, the catalytic β-subunit of the protocatechuate 4,5-dioxygenase
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LigAB from Sphingomonas paucimobilis (47)(102). LigAB is a class III nonheme
iron(II)-dependent extradiol-type catechol dioxygenase that catalyzes oxidative cleav-
age of substituted catechols in bacterial aromatic degradation pathways (76). To test
is Memo might have a similar enzymatic activity even though it is missing a Glu in
the vestigial active site (see also section 1.1.2 Memo protein structure is homologous to
non heme iron dioxygenases) we designed an enzymatic cleavage assay with potential
substrates. To 1 mM of substrate 300 nM of purified Memo was added. Enzymatic
activity, aromatic ring opening, was monitored by spectrometric measurement at 280
nm. Interestingly we could detect the cleavage after addition of purified Memo (Figure
4.8)
No MEMO
No MEMO
300 nM MEMO
300 nM MEMO
1 mM Protocatechuate (3,4-dihydroxybenzoic acid) 1 mM  4-Hydroxybenzhydrazide
Figure 4.8: Enzymatic activity of Memo in an aromatic ring opening assay -
To include a control we purified the human protein mCMTP2 the same way from
bacteria as we did for memo. Both purified proteins, Memo and mCMTP2 showed the
same enzymatic activity (Figure 4.9).
This results indicates that the seen activity in the assay is due to bacteria contami-
nation from the purification process. Non-heme dioxygenases are abundant in bacteria
and a small contamination could already lead to the measured activity.
4.4.2 Mho1 with point mutation in the vestigial active site can com-
plement for the wild-type protein
Memo sequence is highly conserved from mammals to yeast and bacteria. Protein
sequence analysis showed more then 50% similarity between the human and the yeast
protein. Especially specific amino acids in the vestigial active site are conserved in
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1 mM Pyrocatechol (1,2-dihydroxybene) 1 mM Protocatechuate (3,4-dihydroxybenzoic acid)
MEMO
MEMO
No
mCTMP2
MEMO
MEMO
No
mCTMP2
Figure 4.9: Enzymatic activity of Memo including a control -
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all kingdoms of live. All organisms expressing a Memo homolog do have three His,
one Cys, and one Asp in this conserved site (see figure 3.1). We hypothesized that if
Memo is an enzyme this conserved amino acids are most likely to be essential for the
enzymatic activity. To test our hypothesis we took advantage of the synthetic lethal
phenotype between mho1∆ and plc1∆. We made several strain where we replaced the
endogenous MHO1 gene with mho1 having mutated His47, His80, and Cys284. We
crossed the newly made mutation strains with a plc1∆ strains, let them sporulate and
dissected the spores (Figure 4.10).
mho1 plc1 plc1mho1
MEMO PLC1X
sporulation and
tetrade dissection
MHO1 plc1 plc1MHO1
MEMO PLC1X
sporulation and
tetrade dissection
mho1H47A mho1H80A
mho1H47A_H80A mho1C284A
Figure 4.10: Complementation of wild-type Mho1 with mutated Mho1 -
If an mho1∆ strain is crossed with a plc1∆ strain and the resulting diploid strain sporulates
only spores having a single gene deletion or are wild-type can grow. All spores having the
mho1∆plc1∆ genotype can not grow (indicated by a white circle). If in a mho1∆ strain
a mutated mho1 with amino acid substitutions in the vestigial active site is reintroduced
all four spores can grow again showing the complementary potential of the point mutated
gene. In the figure the dissection of four strains having reintroduced the mutated genes
mho1H47A, mho1H80A, mho1H47A H80A, and mho1C284A are shown.
All of the point mutated strains could complement for the wild-type gene in this
specific assay. This could mean that a potential enzymatic activity of Mho1 is not
needed to rescue the SL phenotype between mho1∆ and plc1∆ or the enzymatic activity
is not dependent on those residues. We could also think of a dual role of Memo, being
an adaptor protein with enzymatic activity. Also a third scenario is possible. While
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our lab was trying to purify human Memo in bacteria we saw that Memo having those
point mutation always ended up in the pellet, meaning they were not soluble anymore.
It could also indicate a miss folding of the protein. So we could speculate that the
enzyme in the vestigial active site are essential for the protein folding and 3D structure
and not for enzymatic activity.
4.5 Accumulation of ROS (Reactive Oxygen Species)
Preliminary results in our laboratory showed that MEMO KO or KD cells are more
sensitive to ROS-inducing stress conditions. If MEMO KO cells were grown in medium
containing the ROS inducer CoCl2 they showed a higher rate of apoptosis compared
to wild-type MEFs. To check if the induced apoptosis in is due to higher ROS levels
in MEMO depleted cells we performed a flow cytometry based assay for measuring
intracellular ROS levels. We used the Image-iT LIVE Green Reactive Oxygen Species
Detection Kit from Molecular Probes (Invitrogen) and the wild-type and MEMO KO
MEFs. Intracellular ROS levels could be made detectable by the conversion of a dye
by ROS to a fluorescent product. This made it possible to measure ROS levels with
FACS by using standard fluorescent filter sets. This kit uses tert-butyl hydroperoxide
(TBHP) to induce ROS. The wild-type and MEMO KO MEFs were grown in DMEM
supplemented with 10% FCS to 80-90% confluency in 10 cm dishes. ROS was induced
by TBHP for 1 hour. We measured twice 20’000 cells for each condition
FACS measurement of ROS induced wild-type and MEMO KO MEFs are shown
in Figure 4.11. Both, MEMO wild-type and KO cells showed the same levels of intra-
cellular ROS and both have same numbers of dead cells 4.11 showing that short time
treatment of MEMO KO cells does not make them more apoptotic then wt MEFs.
In figure 4.12 the superimposition of the analyzed wild-type and MEMO KO MEFs.
All cells were induced the same way for 1 hour and do not show any difference in ROS
levels, indicated by the nice overlay of all FL1-H intensity curves.
It is more likely that the observed increase in apoptotic cells after ROS induction
in MEMO KO cells is due to higher sensitivity to ROS and not to higher ROS levels in
KO cells. It is comparable to temperature sensitive mutants, they stop growing or die
when shifted to the non permissive temperature so it seems that MEMO KO cells enter
98 4. RESULTS
wild-type
KO MEFs
a b
c d
Figure 4.11: FACS measurement of ROS induced wild-type and MEMO KO
MEFs - In the panels (a) and (c) we set the gate to select for living cells. The FSC-H
axis shows the cell size and the SSC-H axis shows cellular density. In the panels (b) and
(d) the actual measurement for intracellular ROS levels is shown. The FL1-H axis shows
the intensity of fluorescent light which correlates with the levels of intracellular ROS.
Figure 4.12: Superimposition of ROS levels in wild-type and MEMO KO MEFs
- This figure shows the superimposition of the curves showing intracellular ROS levels in
wild-type and MEMO KO MEFs. All curves nicely overlay indicating no difference in ROS
levels after induction with TBHP.
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apoptosis when internal ROS levels are above a given threshold whereas wild-type cells
still are fine.
The same ROS sensitive phenotype could not be found in yeast cells. mho1∆ and
wild-type cells did not show any difference in growth when grown in medium containing
CoCl2 or H2O2. We also tried to use the Image-iT LIVE Green Reactive Oxygen Species
Detection Kit for labeling the ROS levels in yeast cells but we were not able to get a
good signal for FACS analysis.
4.6 Subcellular fractionation
To illustrate Memo localization in mammalian cells not only by fluorescent and confocal
microscopy we did subsellular fractionation of the three cell lines T47D, MDA-MB-231,
and SKBR3. All of them showed different endogenous levels of the tyrosine kinase
receptor ErbB2. The SKBR3 cells have massive overexpression of ErbB2, T47D show
lower level and in MDA-MB-231 ErbB2 is even lower expressed (Figure 4.13 top line).
We did the subcellular fractionation of those cell lines with cells growing in full medium
(DMEM + 10%FCS) and in full medium and induced for 20 minutes with HRG. We
checked Memo subcellular localization in the cytoplasm (C), nucleus (N), and at the
membrane (M). As membrane marker we used the ER integral protein calnexin and
as marker for the nuclear fraction we choose lamin A/C a protein from the nuclear
envelope (Figure 4.13).
Memo localization in T47D cells when grown in full medium is cytoplasmic but also
nuclear and at the membrane (comparison for protein amount between the fractions is
not possible due to the used protocol, see also material and methods). Upon treatment
with 10 nm of HRG for 20 minutes we could observe a slight accumulation of Memo
in the nucleus and at the membrane (Figure 4.13 top line). The other two cell lines
(MDA-MB-231 and SKBR3) showed similar subcellular Memo distribution (MDA-MD-
231 less nuclear and at the membrane then SKBR3) but induction with HRG hat no
effect on Memo localization (Figure 4.13). We think the the different expression levels of
ErbB2 in the various cell line could be the explanation for this observation. In SKBR3
cells ErbB2 is overexpressed and by this constitutively active, so HRG induction did
not largely effect those cells. MDA-MB-231 cell do not express ErbB, so they are
independent of HRG induction. T47D cells have moderate ErbB2 levels compared to
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T47D MDA-MB-231 SKBR3
ErbB2
calnexin
lamin A/C
Memo + 20min HRG
ErbB2 +  20min HRG
Memo
Figure 4.13: Subcellular fractionation of T47D, NDA-MB-231, and SKBr3
cells - T47D, NDA-MB-231, and SKBr3 cells were incubated in full medium containing or
full medium and stimulated for 20min with HRG, disrupted by glass-glass homogenization
(Dounce) and fractionated into cytoplasmic (C), nuclear (N), and membrane (M) fractions.
Equal volumes were subjected to SDS-PAGE and subsequent immunoblotting. Calnexin
was used as a marker for the membrane and lamin A/C for the nuclear fraction.
SKBR3 cells and do react to HRG induction. This could be the explanation for our
observed shift in Memo localization.
So far we only did confocal microscopy and signal quantification with Memo stained
SKBR3 cells (see the Paper section 3.3.5). The microscopical analysis confirmed the
findings of the subcellular localization of Memo. It would be interesting to confirm
Memo localization in T47D cells by confocal microscopy, because it seems that in those
cells Memo localization changes upon HRG treatment.
5Discussion
5.1 Finding Memo
5.1.1 Localization in mammalian cells
In this study we have shown that Memo localizes predominantly to the nucleus but
can also be found in the cytoplasm and on the membrane upon induction with the
appropriate growth factor. Analysis performed by confocal microscopy showed that
nuclear Memo is evenly distributed throughout the nucleus but is excluded from nu-
cleoli and does not localize to the nuclear membrane. Memo encodes for a nuclear
export sequence (NES) and we demonstrated that Memo gets actively exported from
the nucleus via exportins. Nuclear export could be blocked with addition of leptomycin
B (LMB) to the medium, which lead to an accumulation of Memo and, by this showing
that Memo diffuses by a certain rate through the nuclear pore complex. As Memo is
approximately 33 kDa in size and proteins up to 50 kDa can diffuse through the nuclear
pore complex this seems plausible. Nuclear accumulation of Memo after LMB treat-
ment can be enhanced by inducing the cells with the appropriate growth factor (here
we induced SKBR3 cells with HRG), showing evidence that also the nuclear import
can be directed by active import. When we analyzed the amino acid (AA) sequence of
ErbB2 no classical nuclear localization signal (NLS) was found using bioinformatic pre-
diction tools. Usually NLS consist of bipartite basic AA stretch separated by roughly
10 AAs. Interestingly Memo has a Tyrosine residue at position 210, which was found to
be phosphorylated in a screen (91). Interestingly this site shows the highest probability
to be phosphorylated when using a prediction software (12) and this specific Tyr 210 in
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Memo is conserved throughout evolution (Figure 5.1). Yeast cells, which do not have
any dedicated tyrosine kinases at all, have serine or threonine residues close to that side
and bioinformatic analysis showed (48) that those residues have a high probability to
be phosphorylated (Figure 5.1). We speculate that this phosphorylation is the trigger
to the import from the cytoplasm to the nucleus. Figure 5.2 shows a potential working
model how Memo localization could be regulated in SKBR3 cells.
H. sapienas     -------SQGEIYRSIEHLDKMGMSIIEQLDPV
M. musculus     -------SQGEIYRSIEHLDKMGMSIIEQLDPV
R. norvegicus   -------SQGEIYRSIEHLDKMGMSIIEQLDPV
B. taurus       -------SQGEIYRSIEHLDKMGMSIIEQLDPV
D. rerio        -------SQGEIYRSIEHLDKMGMGIIEQLDPI
C. elegans      -------SSIPIYEQITNMDKQGMSAIETLNPA
D. discoideum   -------KEVPIYKYIEELDRKGMEIIESGDPV
S. pombe        ---RGGPTSPKIYESISNLDHIGMKIIETKSSD
S. cerevisiae   ARSKLSHHQVPIWQSIEIMDRYAMKTLSDTPNG
Figure 5.1: Potential phospho Y-, S-, and T-sites in Memo and Mho1 - The figure
shows a short stretch of a multiple sequence alignment. In red the potential phospho-Y
site is highlighted and how it is conserved throughout evolution. S. pombe have such a
Y-site even though they do not have any dedicated tyrosine kinases. In green the serine and
threonine residues with the highest probability to be phosphorylated are shown (calculated
with the phosphorylation prediction software (48).
5.1.2 Localization in yeast cells
In yeast cells regulation of Mho1 localization seems to be different than in mammalian
cells. Mho1 is never found at the cellular membrane. This may be due to the lack
of dedicated tyrosine-kinases in yeast and the interaction of Memo with ErbB2 (or
tyrosine-kinases in general) a mammalian specific interaction leading to the membrane
localization of Memo. Similar to mammalian cells Mho1 in yeast is also found more
than 60 - 70 % in the nucleus and to a lesser extent in the cytoplasm (see also Figure
3.4D). Mho1 is clearly excluded from the vacuole. This organelle is not present in
mammalian cells but is mostly similar to lysosomes or endosomes.
With our Mho1-GFP fusion strain we showed that Mho1 does not shuttle from
the cytoplasm to the nucleus or vice versa in all tested conditions. However we found
that Mho1 expression levels do respond fast to environmental changes. A change in
growth temperature can lead to up- or downregulation of Mho1 within 20 minutes
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Figure 5.2: Model for Memo-shuttling in SKBR3 cells - 1) HRG binds to ErbB3
2) Hetero-dimerization of ErbB3 with ErbB2 3) Autophosphorylation of Tyrosine residues
in the cytoplasmic tail of ErbB2 4) Memo gets recruited to a specific phospho-Tyrosine
(67) 5) Phosphorylation of the Tyrosine 210 on the surface of Memo 6) Recognition of the
Tyrosine 210 and active import into the nucleus 7) Memo gets dephosphorylated and the
NES of Memo gets recognized by exportins and Memo is actively exported 8) Cytoplasmic
Memo is ”ready” for the next round of activation 9) passive diffusion of Memo through the
nuclear pore complex. If cells are in starvation medium containing LMB they accumulate
Memo in the nucleus suggesting that Memo gets only actively exported or diffusion into
the nucleus is more efficient.
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(35). Changes in the Growth media like nitrogen depletion or growth stationary phase
changes Mho1 expressionlevels within 1 - 2 hours (35). It seems that in yeast cells not
the localization of Mho1 is altered after certain stimuli (heat, cold, nitrogen,...) but
transcription and translation are tightly regulated and by this changing the concentra-
tion of protein in the different organelles.
In mammalian cells experiments showed that Memo levels do not change upon
induction of the cells with HRG or if the cells are starved or grown in full media. We
speculate that Memo/Mho1 localization in both, mammalian and yeast cells, is essential
for proper function but the regulation is different. In mammalian cells Memo can freely
diffuse in and out the nucleus but upon stimulation the protein gets actively imported
and exported from the nucleus. We proved that by blocking the nuclear export with
leptomycin B in unstimulated and stimulated cells and quantified protein concentration
with confocal microscopy and measuring fluorescent intensity. In yeast cells where Mho1
is predominantly nuclear the protein level is efficiently up- or downregulated in reaction
to various external stimuli. In the figure 5.3 we show a model for Mho transcriptional
control and localization in yeast.
°C - nitrogen
starvation
C-source
Figure 5.3: Model for transcriptional control and localization of Mho1 in yeast
cells - Mho1 protein levels vary according to the intensity of green in the figure. A cell
growing in log-phase express about 300 - 350 molecules per cell (37). After the cells sense
”stress” induction Mho1 gets upregulated, most likely via Msn2/Msn4. The localization of
the Mho1 protein remains the same but at much higher level (indicated by the dark green
color). In some ”stress” condition Mho1 gets upregulated more than 32-fold (35).
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5.2 Is Memo an Enzyme?
We tested if Memo could have an class III non-heme dioxygenase activity like its struc-
tural homolog LigAB from Sphingomonas paucimobilis. In an enzymatic activity assay
developed by us we measure the cleavage of an aromatic ring. We could show that Memo
and mCTMP2 (the Akt inhibitor CTMP (carboxyl-terminal modulator protein (72))
we used as negative control) showed the same enzymatic ”activity”. As both proteins
were expressed and purified by the same protocol in bacteria, this is likely the observed
dioxygenase activity is ”contamination” from the purification process. Dioxygenases
are widely expressed in bacteria only tiny amounts of contamination could explain the
observed enzymatic activity. Second, Protocatechuate one of the substrates used in our
assay is a substrate for protocatechuate 3,4-dioxygenase that belong to the intradiol
family of non-heme dioxygenases (17, 33, 34) not to the extradiol family of non-heme
dioxygenases like LigAB. This supports our hypotesis that the observed activity is due
to cross-contamination and not due to the enzymatic activity of the purified proteins.
It is unlikely that Memo encodes for a dioxygenase of this class. First no specific
enzymatic activity for Memo could be observed in our assay and second all known
class III dioxygenases have a Glu in the active site and use non-haem Fe(II) or non-
haem Fe(III) to cleave the aromatic ring (16). Qiu et. al (89) showed that the iron-
coordinating glutamate found in dioxygenases is replaced with a cysteine in Memo and
no evidence for iron binding was found by (89).
5.2.1 If not a dioxygenase, could Memo be an other enzyme?
There are some speculations that Memocould be an enzyme in archea. In Methanocal-
dococcus jannashii all but one enzymatic step from the mevalonate pathway are known
(Figure 5.4). The only missing enzyme in the archeal mevalonate pathway is the enzyme
which decarboxylases mevalonate phosphate to isopentyl phosphate.
Grochowski et. al (42) propose that the protein MJ0304 (the Momo homolog of
M. jannaschii) could be the missing link. They base their hypothesis on chromosomal
alignment of genes. In most archeal species genes encoding for proteins of a pathway
colocalize together on the chromosome. Analysis of archea ”operons” showed that
homologs of MJ0304 often are on the same chromosomal stretch as genes coding for
enzymes of the mevalonate pathway (Figure 5.5)
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Figure 5.4: Mevalonate pathway in archea and eukaryotes - The figure shows the
mevalonate pathway ant the difference in archea and other eukaryotic cells. The only un-
known enzyme is the phosphomevalonate decarbocylase. Grochowski et. al (42) speculate
that this decarboxylase step could be done by the Protein MJ0304. Interestingly MJ0304
is the archeal homolog of Memo (Figure adapted from (42)).
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M. thermoautotrophicum
A. Fulgidus
P. furiosus
M. mazei
S. solfataricus
A. perinx
M. jannaschii
homolog of Memo / Mho1
adapted from Laura et. al, 2006
Figure 5.5: Chromosomal organization of genes coding for mevalonate pathway
enzymes in representative archaea. - The corresponding genes from M. jannaschii are
indicated for comparison but are not colocalized on the chromosome (Figure adapted from
(42). Highlighted with a red round rectangle is MJ0304, a potential decarboxylase and the
archeal homolog of Memo.
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It is unlikely that Memo / Mho1 are decabocylases in the mevalonate pathway. In
eukaryotes all enzymes of the mevalonate pathway are known and it is highly improbable
that Memo / Mho1 are a ”backup carbocylase” in case the first fails its job. It is still
possible that Memo has decarboxylase or another enzymatic activity.
Could memo then be an other decarboxylase? We do not known. There is no screen
for decarbocylases and as we do not know the potential substrate we can not run an
enzymatic activity assay.
So far we can not exclude a potential enzymatic activity of Memo. I hope that
people from the Hynes lab are going to solve the Memo riddle in the near future!
5.3 MHO1 and PLC1 are synthetic lethal in S. cerevisiae
In a synthetic lethal screen done by Maria Maira in the lab of Prof. Matthias Peter in
Zu¨rich PLC1 showed up as a potential synthetic lethal interaction partner of MHO1.
PLC1 was the only hit in this SL screen. We then made the two single deleted haploid
deletion strains and after mating and dissection of the resulting spores we showed that
all double deleted spores could germinate but stopped in proliferation after 2 - 10 cell
cycles. This let us hypothesize that according to the amount of Plc1 or Mho1 protein
the individual spores got from the mother cell defines how many cell cycles the double
deleted cells can undergo until the stop dividing as a result of not enough Plc1 or
Mho1 in the cell. By reintroducing a CEN/ARS plasmid expressing PLC1 under its
endogenous promotor we could rescue the SL phenotype and as soon as the cells lost
the plasmid again growth was inhibited. This proved that the observed SL phenotype
is a true stop in proliferation and SL is not only observed due to a germination defect
of the double deleted spores.
5.3.1 Rescue with PLC1 expression
We could also rescue the SL phenotype of plc1∆ and mho1∆ by replacing the en-
dogenous MHO1 gene with its human homologue MEMO. This showed us that even
though Memo was found as a phospho-tyrosine binding protein which pulls-down with
ErbB2 and yeast do not have any dedicated tyrosine kinases at all, the human gene can
complement for its yeast homologue in this assay. We propose that this rescue can be
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explained with a conserved ”activity” of Memo or an other function other than P-Typ
binding of Memo.
5.3.2 Mutation of the vestigial active site
As shown in Figure 1.2 Memo and the class III non-heme dioxygenase show struc-
tural homology. Memo has a altered ”active” site compared to the dioxygenase and
expresses two histidine and one glutamate where the dioxygenase has two histidine and
a cysteine. Nevertheless we showed that all the amino acids facing the vestigial active
site in Memo are conserved throughout evolution (Figure 3.1B). We mutated those
amino acids in the yeast gene by site-directed mutagenesis to create the the mutated
genes: mho1H47A, mho1H80A, mho1H47A H80A, and mho1C284A. Our idea was that
if Memo is an enzyme the point mutation of these evolutionary highly conserved amino
acids might impair the enzymatic activity. Because we do not know the potential sub-
strate of the hypothetical enzyme Mho1/Momo we could not develop an enzymatic
activity assay with cell lysates or purified protein. Instead we took advantage of the SL
phenotype between mho1∆ and plc1∆. We replaced the endogenous MHO1 gene with
the potentially active dead mutations we made (point mutations in the vestigial active
site). All tested point mutations could rescue for the wild type gene. However the
mho1C284A mutations showed a slow growing phenotype when compared to the other
tested mutations an the wild type gene. This suggest that the Cys284 has a crucial role
in the proper unction of Mho1. We did not the test the triple mutation of all three His
in the vestigial active site, but the single and double point mutation of the His to Ala in
the vestigial active site did not show a phenotype in our complementation assay. This
result could be an other hint that Mho1/Memo is not an enzyme, but one could also
argue that Mho1 does not need an enzymatic activity to rescue the SL phenotype. We
can only say that the mutations of the two histidine 47 and 80 to alanine did not affect
the rescue of the synthetic lethality, so Mho1H47A H80A did fulfill the same function
than the wild-type protein in this assay. The plc1 ∆ mho1A284C mutated strain was
a bit slower growing but the mutated protein could also complement for the wild-type
protein (see Figure 4.10).
We showed that Memo is not only conserved from bacteria to human but the human
gene can also complement for its yeast homolog. We also made various expression
vectors for use in mammalian cells expressing the yeast gene MHO1 combined with
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several Tags and GFP. We would like to answer the question if the yeast gene can
complement for the human gene in migration and adhesion assays and where the yeast
protein localizes to in a mammalian cell.
But the main question remains still unanswered: ”Why are MHO1 and PLC1
synthetic lethal?”
5.4 Can the microarray results explain the SL phenotype
of mho1∆ and plc1∆
In mammalian cells Memo gets recruited to the membrane after induction with growth
factors like HRG or EGF. We also showed that Memo can be imported and exported
actively from the nucleus. However Mho1/Memo is predominantly found in the nucleus
in yeast and mammalian cells. Due to this localization pattern we wanted to know if
Mho1 could be a transcription factor or if Mho1 regulates transcription of other genes.
In a microarray experiment we compared gene expression in wild-type, mho1∆, and
plc1∆ strains. Because Mho1 is highly upregulated in stationary phase we harvested
the cells in mid-log phase and after 48 h growth in YPD.
Analysis of the data showed that wild-type and mho1∆ strains show almost the same
gene expression patterns. Only mRNA levels of a few genes was altered between wild-
type and mho1∆ strain in both conditions. That the array data comparing the mRNA
levels of wt and deletion strain grown to mid-log phase showed almost no changes (see
table 4.1) could be explained by the fact that there is little Mho expression when yeast
cells are grown under these conditions, but also when cells were harvested after 48 h
of growth in YPD most genes expression patterns were unchanged (see table 4.2) even
though Mho1 is upregulated up to 16 fold or even more under these conditions (35).
The results from our microarray comparing gene expression of wild-type and mho∆
strains grown in mid-log phase and 48 h in stationary phase showed almost no differ-
ence between the two strains. This finding together with the fact that the Mho1/Memo
protein does not show any known DNA binding domain let us conclude that is highly
unlikely that Mho1 is a transcription factor. Also it does not look like Mho1 influ-
ences the transcription of other genes in the cells. In our microarray results only in
both conditions only 9 genes were up or down regulated in mho∆ strains compared
to wild-type. All but one of them are ”dubious open reading frames” or ”protein of
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unknown function”. The biggest expression change between the two strains showed the
gene YEL020C-B which was more then 8-times downregulated in a mho∆ strain when
grown to stationary phase. YEL020C-B encodes for a ”dubious open reading frame un-
likely to encode for a protein”. The only ”known” gene showing up in our micro array
experiment was LSM5. In mho∆ LSM5 is approximately 2-fold downregulated com-
pared to wild-type strains. Lsm5 is part of two heteroheptameric complexes, Lsm2p-7p
and either Lsm1p or Lsm8p. The complex containing Lsm1-7p is predominately cyto-
plasmic and mutations in that complex all cause defects in mRNA degradation (45)(9).
It was also shown that depletion of the essential proteins Lsm2-5p or Lsm8p are defec-
tive in processing tRNA (59), rRNA (57), and snoRNA (58). However, we do not think
that the downregulation of LSM5 in mho∆ strains has an effect on the cell. As Lsm5 is
involved in mRNA decay a significant downregulation of the protein would have a big
effect on the mRNA levels in our microarray experiment, but almost all mRNA levels
are the same as in wild-type. Because we did a tiling array, we were also able to detect
other classes of RNA, like tRNA, rRNA, or snoRNA. Again, if LSM5 would be signifi-
cantly downregulated we would expect a lot of RNAs to show up, but we detected only
two tRNAs and one snoRNA to be changed in all experimental setup. Even though
Lsm5 is an interesting candidate and give us a lot of possibilities to speculate about its
contribution to the synthetic lethal phenotype between mho1∆ and plc1∆ we showed
that the observed 2-fold downregulation in the mho1∆ strain is not enough to have an
effect on its RNA levels.
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6Materials & methods
6.1 yeast cells
6.1.1 Yeast lysates
6.1.1.1 Yeast lysates for TAPtag assay (MM400)
The appropriate TAP tagged yeast strains were grown in 2 l of YPD to the needed
OD600. In our experiment to OD600 of 2 and 12. The cells were spun down in 1 l
centrifuge bottles at 6000 RPM for 85 minutes min and pellets were resuspended in
100ml H2O and transferred to 250ml bottle and spun in an SLA-1500 rotor at 4000
rpm for 10 min. The pellet was resuspended in 1/4 Volume of 1x lysis buffer (6mM
Na2HPO4, 4mM NaH2PO4*H2O, 1% NP-40, 150 mM NaCl, 2 mM EDTA, 1 mM
EGTA, 50 mM NaF, 4 µg/ml leupeptin, 0.1 mM Na3VO4, and per 50 ml lysis buffer 1
complete tablet, EDTA free (Roche Cat.# 1873580) and 500 mul 0.1 M PMSF). The
cells were then pipetted into a 50 ml Falcon tube containing liquid N2 and stored at
-80C. For the lysis the Retsch (Haan, Germany) MM400 Mixer Mill was used. The two
grinding jars (01.462.0216) and the two grinding balls (05.368.0062) were pre-chilled in
liquid N2 and 7.5g of frozen cell beads were added to each of the grinding jars. Jars
were again chilled in liquid N2 and then grinded for 3 minutes at 30Hz. Chilling and
grinding cycle was repeated another two times (total 9 minutes grinding). The obtained
yeast powder was used for TAP tag purification experiments.
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6.1.1.2 Yeast lysates for western blot and reductase assay
Yeast cells were grown in the appropriate medium to the needed OD600. Cells were
harvested by centrifugation and resuspended in lysis buffer. Acid washed glass beads
were added to the cells in 2 ml eppendorf tubes (Sigma-Aldrich, St. Louis, Missouri).
The tubes were vortexed for 3 times 1 minute at full speed at 4C followed by 5 minutes
on ice. After centrifugation the supernatant was collected and stored at -20C for further
use.
6.1.1.3 Total RNA Isolation from S. cerevisiae
Approximately 50 ml of yeast cultures at OD600=0.5 were harvested by centrifugation
and pellet was resuspended in in 2.4 ml AE Buffer (AE = 50mM NaAcetate pH 5.2,
10mM EDTA) and transferred to an RNase-free Nalgene (Thermo Fisher Scientific,
NY) Oak Ridge phenol-resistant centrifuge tube (15 ml size). 160 ?l 25% SDS and 2.4
ml acid phenol (pH 4.3, purchased as unbuffered saturated liquefied phenol (Fischer
BP1751I-400)) were added and mixed by vortexing. After a 10 min incubation at 65C
with vortexing every minute the samples were placed for 5 min on ice. Samples were
spun down for 15 min at 12’000 g (10’000 rpm in a SS-34 rotor) and supernatant was
transferred into a pre-spun (5 min at 1500 rpm) 15 ml Phase Lock Gel tube (Eppendorf,
Hamburg, Germany) and 2.6 ml chloroform (Fischer BP1145-1) was added and mixed
by shaking. Samples were spun down for 10 min at 3000 rpm in a tabletop centrifuge
(Beckman). The supernatant was poured into a new RNase-free Nalgene Oak Ridge
centrifuge tube and 1/10 volume 3M NaAcetate (pH 5.2-5.6) and equal volume of room
temperature Isopropanol were added,mixed and spun down for 45 min at 17’500 g
(12’000 rpm in a SS-34 rotor). The pellet was washed with 1 ml 70% EtOH and spun
again 20 at 17’500 g. EtOH was poured off and pellet was dried in a speed vac on
low heat for 15 min. The pellet was resuspended in 100 µl water and transfer to an
RNase-free Eppendorf tube. Quantitate of RNA was measured with NanoDrop and 1
µg was run on a 1% agarose gel. Expected yields should be around 0.4 mg of total
RNA. The RNA samples were stored at -80C.
6.1. YEAST CELLS 115
6.1.2 Fishing experiments and screens
6.1.2.1 TAP (Tandem Affinity Purification)
All TAP tagged strains are from the Open Biosystems (Huntsville, Alabama) ”Yeast
TAP-Tagged Collection for profiling the yeast proteome”. Picking of the correct strains
was checked by verification PCR with the appropriate oligos. All strains have a C-
terminal TAP insertion cassette contains the coding region for a modified version of
the TAP (Tandem Affinity Purification) tag, which consists of a calmodulin binding
peptide, a TEV (Tobacco Etch Virus) cleavage site and two IgG binding domains of
Staphylococcus aureus protein A, as well as the HIS3MX6 selectable marker. The
background strain is the Mata BY4741.
The strains were inoculated in 10 ml YPD and grown over night at 30C. Next day
the pre-culture was diluted in 2 l YPD and grown at 30C in a shaking incubator (180
rpm) to an OD600 of 2 or 12. The cells were harvested by centrifugation at 4C and
lysed as described above. The yeast powder was used for TAP tag purification. The
TAP tag purification protocol was adapted by Marc Bhler from (90) and (88):
The powder was put in a chilled glass beaker to warm up at room temperature until
it started thawing at the edges. 2 ml of lysis buffer containing freshly added protease
inhibitors was added per g of lysed yeast cells and mixed rapidly with a spatula to obtain
a homogenous suspension. NaCl concentration was increased, if needed more than 150
mM, by adding 5 M NaCl and stirring in the cold room. The lysates were transferred
to a 50 ml Falcon tube and spun at 12’000 rpm for 25 min at 4C. Supernatant was
transferred to a fresh Falcon tube and 400 µl of IgG-Sepharose beads in lysis buffer
(1:1) slurry were added and incubated on a rocker at 4 C for 2 hours. The Falcon
tube was then spun for 3 min at 500g. Supernatant was poured off and the resins
were resuspended in the residual amount of supernatant. Biorad (Hercules, California)
polyprep column were equilibrated with 1ml wash buffer (10 mM Tris-HCl, pH 8.0,
150 mM NaCl, 0.1% NP-40). Lysate and beads were pipetted into a Biorad polyprep
column with a reservoir and another ml of lysis buffer was added to collect all the
beads. The beads were washed 3 times with 10 ml wash buffer followed by a wash
with 10 ml TEV-C buffer (10 mM Tris-HCl, pH 8.0, 150 mM KOAc, 0.1% NP-40, 0.5
mM EDTA, 1 mM DTT). The bottom of the column was closed with a stopper and
transferred at room temperature and 1 ml of room temp TEV-C buffer containing 5
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µl acTEV (50U) was added. The column was sealed and allowed the stand at room
temperature for 1-1.5 hours. The eluate was drained into a new coluomn (equilibrated
with 1 ml CAM-B buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM Mg(OAc)2, 1
mM Imidazole, 2 mM CaCl2, 10 mM βME) and sealed at the bottom). The column was
washed twice with 1.5 ml Cam-B containing 0.1% NP-40 and once with 1.5 ml CAM-B
buffer containing 0.02% NP-40. The column was eluted with CAM-E buffer (10 mM
Tris-HCl, pH 8.0, 150 mM NaCl, 0.02% NP-40, 1 mM Mg(OAc)2, 1 mM Imidazole ,
10 mM EGTA, 10 mM βME) containing 0.02% NP-40 into 1.5 ml eppendorf tubes:
100 µl E1 fraction (void), E2 and E3 fraction, 250 µl and 700 µl respectively. The
E2 and E3 fraction were pooled and split into two equal fractions. Both were TCA
precipitated, one for submission for mass-specometry analysis and one for a gradient
SDS gel, followed by silver staining. TCA purification was done as follows: Cold (4C)
TCA from a 100% stock was added to a final concentration of 20% and incubated
on ice for 20 min followed by full speed centrifugation at 4C. The supernatant was
removed and washed with 1 ml of cold (4C) 10% TCA and spun for 20 min full speed
at 4C. Supernatant was removed and pellet was washed with 1 ml of cold (-20C)
HPLC-grade acetone and spun for 30 min full speed at 4C. Supernatant was removed
and the pellet was air-dried at room temperature. Dried pellet was stored at -80C
before being submitted to the Protein analysis facility. The samples were then Trypsin
digested and analyzed with a LTQ Orbitrap Velos (Thermo Scientific) equipped with
Agilent 1100/1200 Nanoflow LC System for nano-spray MS (Agilent Technologies). For
processing of the results the software Mascot (Matrix Science) was used.
6.1.2.2 dSLAM
The dSLAM screen was done as described in (79) with some slight modification. In
a first step the YKO /yeast knock out) heterozygous diploid strain collection had do
be made mating type selectable. To obtain the mating type selectable cassette the
plasmid pXP346 (79) was cut with SpeI x PstI and run on an 1% agarose gel. The
appropriate band was cut out and extracted from the gel. The obtained cassette
can1∆::LEU2-MFA1pr-HIS3 integrated into the pooled deletion collection by trans-
formation en masse. We obtained approximately 900’000 transformed cells which is
about 150 transformants per deletion strain. Next we made a query construct for inte-
grative transformation. For that we toke the mho1∆::kanMX strain and replaced the
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selection marker with the natMX marker from the plasmid pAG25 (40) or with the
URA3 marker from the plasmid pSO142-2 (79). Genomic DNA from the newly made
strains was used as template for a PCR reaction to create the MHO1 deletion cas-
sette. The two oligos SLS-for (GCCTCACGCACCTTCTATAATACACCAAATAAT-
GTCCACTTCTCATTGCA) and SLS-rev (CGACTACTCCGCTTACATGTTCAAG-
TACGACTCTACTCACGGTAGATACG) were designed to produce a MHO1 deletion
cassette with long flanking homologies (approx. 1.5 kb). This cassette was needed for
en mass deletion of MHO1 in the mating type convertible deletion pool. We obtained
250’000 transformants, approx. 40 transformants per deletion strain. Sporulation, fi-
nal selection and genomic DNA extraction was done as described in (79). TAP-array
PCR, TAG-array-hybridisation on Chip and TAG-array scanning was done at Novartis.
Image and Data analysis was done with the help of Sven Schuierer using the software
spotfire (Tipco, Palo Alto, California).
6.1.2.3 Microarray
For the microarray analysis, total RNA was prepared from cultures grown at 30C in
YPD medium to OD600 = 1.0 (log phase) and OD600 = 12.0 (stationary phase). RNA
was extracted with hot phenol as described in (93). Biotinylated, fragmented cRNA
was hybridized to Affymetrix S. cerevisiae Tiling 1.0R Array. Data analysis and gene
filtering were done using R/Bioconductor (36). Signal condensation was done using
only the RMA from the Bioconductor Affy package. Differentially expressed genes
were identified using the empirical Bayes method (F test) implemented in the LIMMA
package and adjusted with the false discovery rate method (112). Hierarchical clustering
and visualization were done in R. Probe sets with a log 2 average contrast signal of at
least 5, an adjusted P value of ¡0.05, and an absolute log 2 fold-change of ¿0.585 (1.5-
fold in linear space) were selected. The analyses were performed with RNAs harvested
from mho1∆, plc1∆, and wild-type strains.
6.1.3 Enzymatic activity
6.1.3.1 Dioxygenase activity of purified Memo
To check if Memo has a class III extradiol dioxygenase activity we designed an assay us-
ing potential substrates and purified Memo. Purification of Memo was described previ-
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ously in Qui et. al, 2008) (89). As extradiol dioxygenases in bacteria are manly aromatic
ring opening enzymes, we chose the substrates protocatechuate (3,4-dihydroxybenzoic
acid) and pyrocatechol (1,2-Dihydroxybenzene). Enzymatic activity of extradiol dioxy-
genases could be observed by absorption measurement at A260. The opening of the
aromatic ring is detected by a change in the absorption. 300nM of purified protein per
assay was used. As negative control we used the human protein mCTPM2 that was
purified in parallel to Memo.
6.2 mammalian cells
6.2.1 Antibodies and Reagents
Recombinant heregulin β 1 (HRG) was purchased from R&D Systems (Minneapolis,
MN, USA) and solubilized in PBS + 0.1% BSA.
The following antibodies were used:
Memo (70) rat anti-α-tubulin antibody (supernatant from hybridoma cells) 6His
Mcm2
secondary ab:
Alexa-Fluor 546 conjugated anti-rat antibody (Molecular Probes, Eugene, OR)
Alexa-Fluor 488 conjugated anti-mouse antibody (Molecular Probes, Eugene, OR)
6.2.2 Cell Culture
MEFs (Mouse Embryonic Fibroblasts) and SKBr3 breast tumor cells were cultured in
Dulbecco‘s modified Eagle‘s medium supplemented with 10% fetal bovine serum (FBS)
(GIBCO Invitrogen, Basel, Switzerland) and 2 mM glutamine at 37 C, 5% CO2.
6.2.3 Microscopy
6.2.3.1 Testing of the Memo anti-body for IF
We have chosen the Memo inducible KO MEFs for testing the monoclonal Memo anti-
body. In those cells we can get rid of all Memo protein and so clearly define the speci-
ficity of the anti-body in fluorescent microscopy. Both MEFs, wild-type and KO, were
grown in 8-well ibidi µ-slides over night in DMEM containing 10% FCS. Cells were fixed
in 4% PFA and permeabilized with 0.1% Triton-X. As econdary anti body for Memo
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staining we used the Alexa-Fluor 488 conjugated anti-mouse antibody. Microtubules
were stained with a rat anti tubulin anti body and withe a secondary Alexa-Fluor 546
conjugated anti-rat antibody. Nucleus was visualized with Hoechst. In the Figure 6.1
the wild-type and the MEMO KO MEFs are shown. The Memo anti body shows a
nice nuclear staining (but excluded from the nucleoli) and a less strong homogeneous
cytoplasmic staining. In the MEMO KO MEFs almost all signal in the green (Memo)
channel is gone if the same parameters for image accusation were applied for both cells.
We concluded that the monoclonal Memo anti body shows a high specificity if used for
IF and only shows a weak unspecific signal in the cytoplasm.
wild-type MEF MEMO KO MEF
@-Memo @-Memo microtubulesmicrotubules
HoechstHoechst merge merge
Figure 6.1: Testing of the monoclonal Memo anti body for IF - The figure shows
wild-type and MEMO KO MEFs stained for Memo using our lab monoclonal mouse anti
Memo anti body. The cells are also stained for microtubules and DNA. Wild-type MEFs
show a clear nuclear Memo staining which is excluded from the nucleoli and a less intense
homogenous cytoplasmic staining. Using the same staining protocol and the same accusa-
tion settings for MEMO KO MEFs almost no single is visible. Only a faint cytoplasmic
single is detectable.
6.2.3.2 Immunofluorescence microscopy
SKBR3 cells were grown on glass coverslips (BD Biosciences, San Diego, CA) coated
with 25 µg/m rat-tail collagen I (Roche Diagnostics) and MEFs were grown on µ-Slides
8well from ibidi (Martinsried, Germany), in DMEM containing 10% FCS at 37C and
stimulated with 10 nM HRG for 20 minutes. Cells were fixed with 4% paraformaldehyde
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and 3% sucrose in PBS, permeabilized in 0.2% Triton X-100 in PBS, and blocked with
1% BSA in PBS before incubation with the primary rat anti-α-tubulin antibody and
mouse anti-Memo antibody. Alexa-Fluor 546 conjugated anti-rat antibody (Molecular
Probes, Eugene, OR) and Alexa-Fluor 488 conjugated anti-mouse antibody (Molecu-
lar Probes, Eugene, OR) were used as secondary antibodies. F-actin was stained at
room temperature with 2 U/ml FITC-labeled phalloidin (Molecular Probes, Eugene,
OR). Cells were washed with PBS-Tween 0.1% and mounted with a mounting solution
(ProLong Gold Antifade Reagent, Molecular Probes). Mounted samples were examined
using Axioimager Z1 microscope (Carl Zeiss, Feldbach, Switzerland) or using the Laser
Scanning Microscope Axio Imager Z2 with the LSM 700 scanning head.
Pictures from MEFs were taken with the following equipment: The Axioimager Z1
microscope (Carl Zeiss, Feldbach, Switzerland) was equipped with a X-Cite 120 EXFO
Metal Halide for fluorescence and Halogen for TL, a motorized XYZ stage, and a Plan-
APOCHROMAT 100x/1.4 DIC Oil objective. GFP/Alexa488 (Zeiss #10) and DAPI
(Zeiss #49) filter sets were used (Carl Zeiss, Feldbach, Switzerland). Fluorescence
excitation was controlled by a shutter. We used an AxioCam MRm (1388 x 1040 pixels,
Pixel size 6.45 µm) back-illuminated cooled charge-coupled device camera mounted on
the primary port. We used the AxioVision software from Zeiss for data acquisition,
processing and analysis.
Pictures from SKBR3 cells were taken with the following equipment: Axio Imager
Z2 with the LSM 700 scanning head was equipped with the Laser lines: 405 (5mW), 488
(10mW), 555 (10mW), 639 (5mW); and the Lights: Coolled 405, 490, 565 (RL), Halogen
(TL), a motorized XYZ stage, and the objectives: Plan-Apochromat 20x/0,8 M27; EC
Plan-Neofluar 40x/1,30 Oil M27; Plan-Apochromat 63x/1,40 Oil DIC M27. The Axio
Imager Z2 had 2 Epifluorescence PMTs and 1 Transmission PMT. For acquisition we
used the ZEN2010 software from Zeiss. Data were further processed and analyzed with
Imaris from Bitplane Scientific Software (Zurich, Switzerland).
6.2.4 Subcellular fractionation
The cells were washed and detached by scraping in PBS, then homogenized and fraction-
ated following the Membrane Preparation by Homogenization protocol from Current
Protocols in Cell Biology online (Unit 7.10, support protocol 1; Wiley Interscience,
John Wiley & Sons Inc, Malden, MA). All buffers were supplemented with either 10
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µM CaCl2 or 1 mM EGTA. Equal volumes of each fraction were used for subsequent
SDS-PAGE and western blotting with specific antibodies.
6.2.5 Analysis of intracellular ROS levels by FACS
To elucidate if MEMO KO MEFs accumulate more ROS than wild-type MEFs after
stress induction we performed a flow cytometrs assay to measure intracellular ROS
levels. We used the Image-iT LIVE Green Reactive Oxygen Species Detection Kit
from Molecular Probes (Invitrogen) and the wild-type and MEMO KO MEFs. All
chemicals and reagents were provided with the mentioned kit.
The wild-type and MEMO KO MEFs were grown in DMEM supplemented with
10% FCS to 80-90% confluency in 10 cm dishes. Medium was changed to PBS/Ca/Mg
buffer which was supplemented with carboxyl-H2DCFDA to a working concentration of
25 µM. Cells were protected from light and incubated for 60 minutes at 37C. Medium
was changed to DMEM plus 10% FCS supplemented with 100 µM TBHP (tert-butyl
hydroperoxide) to induce ROS. Negative control cells were put in DMEM plus 10%
FCS. ROS was induced for 60 minutes at 37C and 5% CO2. Cells were then washed
with PBS/Ca/Mg. Cells were detached with 0.0% Trypsin/EDTA (invitrogen) and kept
on ice in PBS/Ca/Mg for FACS analysis. Cells were quickly analyzed by fluorescent
microscopy to ensure prober induction of ROS in induced cells and the lack of signal in
the control cells. Cells were measured by FACS detecting fluorescence with the FL-1
H channel (505-530 nm). Foreach duplicate we measured 20’000 cells.
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7Appendix
7.1 microarray - alternative analysis
To get more information out of the microarray analysis discussed in the section ”4.3 Mi-
croarray(Does Mho1 control transcription?)” we used an other approach to to analyze
the data.
We used a wild-type, a mho1∆, and a plc1∆ strain. Each strain was grown to
mid-log phase and to stationary phase. The microarray was performed as described in
”materials and methods”.
First we determined the fold change of each gene in each strain when stationary
phase is compared to mid-log phase. We then knew how each strain regulates its gene
sets. Second we compared the changes of each group to the other two, e.g. the genes
which are up-regulated in a wild-type strain when stationary phase is compared to
mid-log phase are compared to genes up-regulated in a mho1∆ strain when stationary
phase is compared to mid-log phase. So we compared all three strains agains each other
and displayed the results in a Venn diagram (see Figure 7.1). As threshold we choose
a fold change of 1.5 . This means a gene has to be up- or down-regulated at least 1.5
fold more in one strain when stationary phase is compared to mid-log phase then in an
other.
In Figure 7.2 the Venn diagram of the up-regulated genes are shown. In this figure
it is shown that 46 genes are at least 1.5 fold more up-regulated in a mho1∆ strain
then in a wild-type or plc1∆ strain. And 52 genes are up-regulated in mho1∆ or plc1∆
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Figure 7.1: How to interpret the Venn diagram - The three circles represent the
genes up- or down regulated in stationary phase compared to mid-log phase. In 7 all the
genes are represented which are regulated the same for all three strains. In 1 only genes
are present which are unique for the mho1∆ strain, and so on...
strains but not in a wild-type strain. The gene names and the log2 fold change are
shown in Figure 7.3
The same analysis we also did for all the genes being down regulated when stationary
phase is compared to mid-log phase. The Venn diagram is shown in Figure 7.4 and the
list of genes in Figure 7.5 shows the 104 genes downregulated at lest 1.5 fold more in
the mho1∆ strain compared to wild-type and plc1∆ strains and in Figure 7.6 the genes
significantely more gownregulated in mho1∆ and plc1∆ strains compared to wild-type.
What does this result mean? What is the biological relevance of these results?
As here we are comparing two rations against each other and the maximal difference
a fold change of two we think the observed differences between the mho1∆ and the wild-
type strain is experimental noise. By comparing the absolute values between the two
strain in each of the observed conditions no significant difference was observable (see
section ”4.3 Microarray(Does Mho1 control transcription?)”).
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Figure 7.2: Venn diagram of UP-regulated genes -
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Sys. Name Com. Name logFC Sys. Name Com. Name logFC
1 Q0065 AI4 1.085 HRA1 HRA1 0.96713
2 YBR021W FUR4 0.613 TLC1 TLC1 0.61264
3 YBR033W EDS1 0.726 YAR029W 0.82564
4 YCL004W PGS1 0.588 YBR005W RCR1 0.70764
5 YCR025C 0.597 YBR126W-A 0.71245
6 YCR063W BUD31 0.624 YBR180W DTR1 0.59254
7 YDR126W SWF1 0.634 YCR037C PHO87 0.64276
8 YDR319C YFT2 0.652 YDL175C AIR2 0.73144
9 YDR402C DIT2 0.694 YDR098C-B 0.81107
10 YDR476C 0.625 YDR129C SAC6 0.59328
11 YDR490C PKH1 0.705 YDR132C 0.73448
12 YEL028W 0.852 YDR246W TRS23 0.64038
13 YEL062W NPR2 0.644 YDR261W-B 0.60605
14 YEL071W DLD3 0.602 YDR517W GRH1 0.65123
15 YER038C KRE29 0.686 YEL065W SIT1 0.69361
16 YGL263W COS12 0.836 YFL029C CAK1 0.79436
17 YGR010W NMA2 0.622 YFR030W MET10 0.67683
18 YGR011W 0.785 YFR034W-A 0.962
19 YGR212W SLI1 0.589 YGL002W ERP6 0.5988
20 YHR022C 0.613 YGL034C 0.77978
21 YIL134C-A 0.647 YGL114W 0.59408
22 YJL052C-A 0.93 YGL158W RCK1 0.62315
23 YJL136W-A 0.75 YHL009C YAP3 0.60074
24 YKL055C OAR1 0.621 YHL030W-A 1.98581
25 YLR235C 0.592 YIL102C 0.77732
26 YLR237W THI7 0.725 YJL027C 0.73831
27 YLR315W NKP2 0.64 YJL094C KHA1 0.63647
28 YLR316C TAD3 0.625 YJR137C ECM17 0.73292
29 YLR446W 0.884 YLR097C HRT3 0.63179
30 YML066C SMA2 0.586 YLR151C PCD1 0.71077
31 YMR007W 0.674 YLR157W-D YLR157W-A 2.20561
32 YMR182C RGM1 0.658 YLR412C-A 0.67273
33 YMR316C-A 0.933 YMR004W MVP1 0.60053
34 YNL008C ASI3 0.654 YMR077C VPS20 0.66662
35 YNL095C 0.587 YMR135W-A 0.63058
36 YNL114C 1.233 YMR154C RIM13 0.62434
37 YNL204C SPS18 0.594 YNL033W 0.80253
38 YNL329C PEX6 0.598 YNL046W 0.71747
39 YOR382W FIT2 0.685 YNL279W PRM1 0.61379
40 YPL006W NCR1 0.589 YOL013C HRD1 0.59775
41 YPL133C RDS2 0.621 YOL073C 0.73685
42 YPL251W 1.39 YOL147C PEX11 0.66601
43 YPR066W UBA3 0.599 YOR010C TIR2 0.75158
44 YPR085C ASA1 0.587 YOR072W-A 0.91181
45 snR51 SNR51 0.716 YOR075W UFE1 0.59066
46 snR70 SNR70 0.825 YOR107W RGS2 0.62225
47 YPL151C PRP46 0.64315
48 YPL162C 0.65595
49 YPR040W TIP41 0.62062
50 YPR158C-D 0.67626
51 snR86 SNR86 0.61665
52 tG(CCC)D SUF3 1.03013
1 2
Figure 7.3: List of upregulated genes - 1) Genes only upregulated in mho1∆ strains
and 2) genes upregulated in mho1∆ and plc1∆ strains
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Figure 7.4: Venn diagram of DOWN-regulated genes -
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Sys. Name Com. Name logFC Sys. Name Com. Name logFC
1 YAR008W SEN34 -0.65075 53 YIL068C SEC6 -0.64354
2 YAR015W ADE1 -0.63537 54 YJL072C PSF2 -0.666585
3 YBL036C -0.60839 55 YJL081C ARP4 -0.599185
4 YBL057C PTH2 -0.876105 56 YJL125C GCD14 -0.63153
5 YBR009C HHF1 -0.61297 57 YJR002W MPP10 -0.61983
6 YBR022W POA1 -0.629705 58 YJR112W NNF1 -0.675005
7 YBR073W RDH54 -0.618515 59 YJR141W -0.660955
8 YBR112C CYC8 -0.65732 60 YKL042W SPC42 -0.587665
9 YBR161W CSH1 -0.60706 61 YKL082C RRP14 -0.70801
10 YBR202W MCM7 -0.642525 62 YKL108W SLD2 -0.60682
11 YBR254C TRS20 -0.810015 63 YKR008W RSC4 -0.723105
12 YCR052W RSC6 -0.664525 64 YLR095C IOC2 -0.65395
13 YCR077C PAT1 -0.65394 65 YLR319C BUD6 -0.721715
14 YDL043C PRP11 -0.68753 66 YLR330W CHS5 -0.619145
15 YDL092W SRP14 -0.860395 67 YML009W-B YML010W-A -0.66249
16 YDL099W BUG1 -0.752245 68 YML061C PIF1 -0.708765
17 YDL118W -0.999255 69 YMR005W TAF4 -0.68563
18 YDL119C -0.59716 70 YMR016C SOK2 -0.58978
19 YDL179W PCL9 -0.66168 71 YMR158W MRPS8 -0.719785
20 YDL187C -0.95519 72 YMR178W -0.646295
21 YDL235C YPD1 -0.670935 73 YMR233W TRI1 -0.74824
22 YDR052C DBF4 -0.636175 74 YMR321C -0.986925
23 YDR167W TAF10 -0.600795 75 YNL122C -0.590945
24 YDR240C SNU56 -0.629665 76 YNL140C -1.74378
25 YDR396W -0.635885 77 YNL212W VID27 -0.6648
26 YDR397C NCB2 -0.69565 78 YNL213C -0.6651
27 YDR469W SDC1 -0.787855 79 YNL252C MRPL17 -0.65393
28 YDR510C-A -0.82388 80 YNL272C SEC2 -0.616955
29 YDR510W SMT3 -0.715765 81 YOL006C TOP1 -0.661415
30 YDR514C -0.675735 82 YOL028C YAP7 -0.61975
31 YEL017W GTT3 -0.75083 83 YOL038C-A -0.7617
32 YEL020C-B -2.979025 84 YOL070C NBA1 -0.691065
33 YEL037C RAD23 -0.70773 85 YOL144W NOP8 -0.633865
34 YER001W MNN1 -0.788755 86 YOR076C SKI7 -0.723415
35 YER059W PCL6 -0.5986 87 YOR252W TMA16 -0.641355
36 YER063W THO1 -0.73968 88 YOR306C MCH5 -0.66177
37 YER064C -0.631755 89 YPL007C TFC8 -0.650765
38 YER112W LSM4 -0.695575 90 YPL038W MET31 -0.75321
39 YER151C UBP3 -0.694905 91 YPL051W ARL3 -0.664535
40 YER165C-A -0.605695 92 YPL127C HHO1 -0.68846
41 YGL061C DUO1 -0.74662 93 YPL199C -0.763925
42 YGL122C NAB2 -0.608475 94 YPL204W HRR25 -0.58734
43 YGL188C-A -0.914595 95 YPL225W -0.726885
44 YGL244W RTF1 -0.64098 96 YPR046W MCM16 -0.806755
45 YGL246C RAI1 -0.64859 97 YPR055W SEC8 -0.632595
46 YGR047C TFC4 -0.64804 98 YPR104C FHL1 -0.64242
47 YGR092W DBF2 -0.602395 99 YPR105C COG4 -0.651305
48 YGR140W CBF2 -0.6546 100 YPR107C YTH1 -0.61865
49 YGR271C-A EFG1 -0.79754 101 YPR120C CLB5 -0.603105
50 YGR276C RNH70 -0.63751 102 YPR173C VPS4 -0.68484
51 YHR167W THP2 -0.657265 103 YPR175W DPB2 -0.61632
52 YIL008W URM1 -0.63462 104 snR72 SNR72 -0.686595
1
Figure 7.5: List of down upregulated genes for mho1∆ - 1) Genes only downreg-
ulated in mho1∆ strains
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Sys. Name Com. Name logFC
1 YAL024C LTE1 -0.60884
2 YBR094W PBY1 -0.656315
3 YCL014W BUD3 -0.67685
4 YCR013C -1.253455
5 YDL096C OPI6 -0.734
6 YDR228C PCF11 -0.745425
7 YDR310C SUM1 -0.70708
8 YDR424C DYN2 -0.6589
9 YDR468C TLG1 -0.6752
10 YEL007W TOS9 -0.79289
11 YEL053W-A -0.830495
12 YGL068W MNP1 -0.77291
13 YGR082W TOM20 -0.657985
14 YGR084C MRP13 -0.781145
15 YGR091W PRP31 -0.615135
16 YGR233C PHO81 -0.60495
17 YHR012W VPS29 -0.655205
18 YIL041W GVP36 -0.67645
19 YIL138C TPM2 -0.7563
20 YJL115W ASF1 -0.677875
21 YJL173C RFA3 -0.77405
22 YKL119C VPH2 -0.736675
23 YLR021W IRC25 -0.64222
24 YLR096W KIN2 -0.73345
25 YLR337C VRP1 -0.647425
26 YLR354C TAL1 -0.616095
27 YNL070W TOM7 -0.924595
28 YNL121C TOM70 -0.70357
29 YNL185C MRPL19 -0.81541
30 YNL259C ATX1 -0.66965
31 YNR017W TIM23 -0.622385
32 YOL005C RPB11 -0.924305
33 YOL102C TPT1 -0.73365
34 YOR073W SGO1 -0.74521
35 YOR094W ARF3 -0.72123
36 YOR144C ELG1 -0.63969
37 YOR166C SWT1 -0.608125
38 YOR197W MCA1 -0.653435
39 YOR286W AIM42 -0.641065
40 YOR320C GNT1 -0.682665
41 YPL041C -0.63179
42 YPR169W JIP5 -0.636765
2
Figure 7.6: List of down upregulated genes for mho1∆ and plc1∆ - 2) genes
downregulated in mho1∆ and plc1∆ strains
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